{"study_id": 53623, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to examine the impact of noninvasive ventilation (NIV), including continuous positive airway pressure, on heart rate variability (HRV) as a marker of cardiovascular risk in children with obesity and newly diagnosed obstructive sleep apnea (OSA).", "results_summary": "NIV treatment resulted in a small decrease in heart rate and an increase in arousal-related sympathetic-parasympathetic balance, suggesting modest positive impacts on cardiovascular risk. However, no significant changes in HRV parameters were observed overall.", "population_specificity": "Children with obesity and newly diagnosed moderate-severe OSA.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:02.045724+00:00"}
{"study_id": 53621, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to measure nasal gas flow in infants treated with bubble CPAP and compare it with flows used during nasal high flow (nHF) treatment.", "results_summary": "The study found that nasal gas flows during bubble CPAP in preterm infants were similar to those used in nHF and increased with higher set CPAP pressures and in larger infants. Delivered flow ranged from 0.5 to 9.0 L/min, with median flows increasing with higher CPAP pressures.", "population_specificity": "Clinically stable preterm infants receiving bubble CPAP therapy, with a mean gestational age of 28.4 weeks and birth weight of 1154 g.", "effective_dosage": "Delivered flow ranged from 0.5 to 9.0 L/min, varying with CPAP pressures (e.g., median 3.5 L/min at CPAP 5 cm H2O).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:02.447031+00:00"}
{"study_id": 53628, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of telehealth management for improving access, efficiency, and outcomes in the evaluation, testing, and treatment of OSA, including CPAP therapy.", "results_summary": "The study suggests that telehealth options can enhance OSA care by improving access, reducing time to diagnosis and treatment, and enabling better data collection for analytics and targeted support, including CPAP and non-CPAP treatments.", "population_specificity": "Patients with obstructive sleep apnea (OSA)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:03.462190+00:00"}
{"study_id": 53627, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine whether treating obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) improves depressive symptoms compared to sham CPAP.", "results_summary": "Overall, CPAP did not significantly improve depression scores in OSA patients after three months. However, adherent use of therapeutic CPAP in patients with baseline depressive symptoms was associated with a reduction in symptom scores.", "population_specificity": "126 male OSA patients (age = 51 \u00b1 11 years; BMI = 32.0 \u00b1 5.1 kg/m\u00b2).", "effective_dosage": "Device usage \u22654 hrs/day for adherent users.", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:04.243336+00:00"}
{"study_id": 53629, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of different noninvasive respiratory support modes, including CPAP, for preterm infants with respiratory distress syndrome (RDS).", "results_summary": "CPAP was less effective than NIPPV and BiPAP in reducing the need for invasive mechanical ventilation and treatment failure, with a SUCRA score of 0.13 for MV and 0.32 for treatment failure. However, CPAP was associated with a higher risk of air leaks and nasal injury compared to other modes.", "population_specificity": "Preterm infants with respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:08.205245+00:00"}
{"study_id": 53630, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of seven noninvasive respiratory support modalities, including various forms of CPAP, in preventing reintubation in preterm neonates.", "results_summary": "S-NIPPV, NS-NIPPV, nHFOV, and VF-CPAP were more effective than CF-CPAP in preventing reintubation, with S-NIPPV ranked as the best intervention. CF-CPAP was found to be the least effective modality.", "population_specificity": "Preterm neonates requiring postextubation respiratory support.", "effective_dosage": "Not specified", "study_duration": "Within 7 days of extubation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:09.914824+00:00"}
{"study_id": 53632, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the clinical and cost-effectiveness of high-flow nasal cannula therapy (HFNC) versus continuous positive airway pressure (CPAP) as first-line non-invasive respiratory support in critically ill children.", "results_summary": "The abstract does not provide results, as the study is ongoing and aims to evaluate time to liberation from respiratory support as the primary outcome.", "population_specificity": "Critically ill children aged >36 weeks corrected gestational age and <16 years requiring non-invasive respiratory support for acute illness or post-extubation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:10.298151+00:00"}
{"study_id": 53631, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of continuous positive airway pressure (CPAP) in reducing stroke risk among patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found that CPAP significantly reduced stroke risk in cohort studies and in subgroups with good adherence or moderate to severe OSA, but not in randomized control trials overall.", "population_specificity": "Patients with obstructive sleep apnea, particularly those with stroke or at risk of stroke.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:11.453435+00:00"}
{"study_id": 53633, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the safety, feasibility, and outcomes of noninvasive respiratory support (including CPAP) applied outside the ICU for COVID-19 patients.", "results_summary": "CPAP was used in 49.3% of patients, with a 30-day mortality rate of 30%, similar to other NRS methods. The study found no significant difference in mortality or intubation rates among NRS types after adjusting for confounders.", "population_specificity": "670 consecutive COVID-19 patients (69.3% male, mean age 68\u00b113 years) in nine Italian hospitals.", "effective_dosage": "Not specified", "study_duration": "Data collected between March 1 and May 10, 2020 (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:13.566943+00:00"}
{"study_id": 53624, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the prevalence and predictors of positional obstructive sleep apnea (POSA) and evaluate the outcomes of positive airway pressure (PAP) therapy in patients with POSA and exclusive POSA (e-POSA).", "results_summary": "The study found that POSA and e-POSA were prevalent (53.5% and 20.1%, respectively) and associated with lower PAP therapy adherence and higher risk of treatment withdrawal compared to non-POSA patients. The authors concluded that PAP may not be the optimal treatment for these patients, suggesting a need for alternative therapies.", "population_specificity": "6,437 patients with mild-to-severe obstructive sleep apnea from the Pays de la Loire sleep cohort.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:13.902819+00:00"}
{"study_id": 53635, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of helmet CPAP in improving oxygenation and avoiding intubation in COVID-19 patients with hypoxaemic acute respiratory failure (hARF).", "results_summary": "The study found that helmet CPAP improves oxygenation and reduces the need for intubation in COVID-19 patients with hARF, supported by European consensus, though recommendations are based on expert opinion and limited to critically ill patients. The Surviving Sepsis Campaign does not recommend CPAP for initial management of severe COVID-19.", "population_specificity": "Critically ill COVID-19 patients with hypoxaemic acute respiratory failure (hARF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:17.017579+00:00"}
{"study_id": 53637, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the relationship between inflammation and cognitive deficits in OSAS and explore potential therapies, including CPAP.", "results_summary": "The abstract suggests that CPAP treatment, alongside anti-inflammatory substances, may alleviate IH-induced neurocognitive dysfunction in OSAS patients. However, the primary focus was on inflammation's role rather than CPAP's direct effects.", "population_specificity": "Patients with obstructive sleep apnea syndrome (OSAS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:19.261703+00:00"}
{"study_id": 53636, "supplement_id": 1048, "safety_score": "30", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare gastric insufflation risks at different laryngeal mask cuff pressures (20 cmH2O vs. 60 cmH2O) during mechanical ventilation, including continuous positive airway pressure (CPAP).", "results_summary": "Gastric insufflation occurred less frequently at lower cuff pressure (20 cmH2O) and more often during CPAP than intermittent positive airway pressure. A peak airway pressure of \u226420 cmH2O still induced significant gastric insufflation.", "population_specificity": "164 patients ventilated via laryngeal mask.", "effective_dosage": "Cuff pressures of 20 cmH2O (CP20) and 60 cmH2O (CP60).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:19.676416+00:00"}
{"study_id": 53638, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if Continuous Positive Airway Pressure (CPAP) is clinically effective compared to standard oxygen therapy in patients with confirmed or suspected COVID-19.", "results_summary": "The study evaluated CPAP's effectiveness in reducing tracheal intubation or mortality within 30 days, but specific results for CPAP were not detailed in the abstract. Secondary outcomes included intubation rates, mortality, and hospital stay duration.", "population_specificity": "Inpatients with respiratory failure due to suspected or proven COVID-19 across approximately 60 hospitals in the UK.", "effective_dosage": "Not protocolized; delivered per clinical discretion.", "study_duration": "Until death, intubation, or clinical determination of no further need.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:20.494358+00:00"}
{"study_id": 53640, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "To determine the feasibility of a large-scale trial of prehospital CPAP for acute respiratory failure and assess its potential impact on 30-day mortality.", "results_summary": "Recruitment fell short of the target, CPAP delivery was below the goal (74%), and 30-day mortality remained high (27.3%). The study concluded that prehospital CPAP is unlikely to significantly reduce mortality due to limited compliance and difficulty identifying suitable patients.", "population_specificity": "Adults with respiratory distress and low oxygen saturation despite controlled oxygen treatment in a UK ambulance setting.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:22.542560+00:00"}
{"study_id": 53639, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine the effects of 6 weeks of home CPAP therapy on gas exchange in patients with obesity hypoventilation syndrome who failed CPAP titration due to persistent hypoxemia.", "results_summary": "The study found that CPAP effectively controlled obstructive sleep apnea and significantly reduced hypoventilation and hypoxemia severity in participants who initially failed CPAP titration. Despite persistent hypoxemia during titration, adherent home CPAP therapy improved outcomes.", "population_specificity": "Morbidly obese patients with severe OSA (apnea-hypopnea index > 90 events/h) and severe sleep hypoxemia.", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:22.754535+00:00"}
{"study_id": 53625, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of different types of non-invasive ventilation, including CPAP, in treating obesity hypoventilation syndrome through a network meta-analysis.", "results_summary": "The study reviewed randomized active comparator trials but did not provide specific results on CPAP's efficacy in the abstract. It highlighted the lack of head-to-head comparisons among the four PAP interventions.", "population_specificity": "Patients with obesity hypoventilation syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:23.084489+00:00"}
{"study_id": 53641, "supplement_id": 1048, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether intraoperative use of CPAP could protect against pulmonary atelectasis and improve postoperative pulmonary function in overweight patients undergoing spinal anesthesia.", "results_summary": "CPAP significantly improved pulmonary function (FEV1, FVC, PEFR) compared to the control group, particularly 20 minutes post-surgery. No postoperative pulmonary complications were reported in either group.", "population_specificity": "Overweight patients undergoing surgeries under spinal anesthesia.", "effective_dosage": "Not specified", "study_duration": "Intraoperative (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:24.798496+00:00"}
{"study_id": 53644, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether liraglutide, a weight-loss therapy for type 2 diabetes, could improve the severity and symptoms of obstructive sleep apnoea (OSA) compared to or in combination with continuous positive airway pressure (CPAP).", "results_summary": "The abstract does not provide specific results regarding CPAP's effects, as the study focuses on evaluating liraglutide's impact on OSA severity and symptoms in patients with obesity and type 2 diabetes.", "population_specificity": "Patients with newly diagnosed OSA (AHI \u226515 events/hour), obesity, and type 2 diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:29.043377+00:00"}
{"study_id": 53642, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the association of obstructive sleep apnea (OSA) with inflammatory markers (TNF-\u03b1 and IL-6) and evaluate the effect of short-term CPAP therapy on these markers.", "results_summary": "OSA patients had higher baseline levels of TNF-\u03b1 and IL-6 compared to non-OSA controls, but one month of CPAP therapy did not significantly alter these inflammatory markers. No group or interaction effects were observed after adjusting for covariates.", "population_specificity": "Patients referred for diagnostic polysomnography, divided into OSA intervention, OSA untreated control, and non-OSA control groups.", "effective_dosage": "Not specified", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:29.652656+00:00"}
{"study_id": 53643, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether noninvasive ventilation failure (including Continuous Positive Airway Pressure) was associated with severe tracheal intubation-associated events and severe oxygen desaturation in critically ill children.", "results_summary": "Noninvasive ventilation failure was not independently associated with severe tracheal intubation-associated events but was linked to severe desaturation, though this association lost significance after controlling for baseline differences. Higher FIO2 before intubation in the noninvasive ventilation group was associated with severe events.", "population_specificity": "Critically ill children in 13 PICUs across the United States and Canada.", "effective_dosage": "Not specified (use of high-flow nasal cannula, CPAP, or bilevel noninvasive ventilation in the 6 hours prior to intubation).", "study_duration": "Median of 13 hours (interquartile range, 4-38 hours) of noninvasive ventilation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:30.161580+00:00"}
{"study_id": 53647, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of four body positions on cardiorespiratory stabilization and comfort in preterm infants receiving Nasal Continuous Positive Airway Pressure (NCPAP).", "results_summary": "The study found no statistically significant differences in heart rate, respiratory rate, or oxygen saturation across the four positions. However, comfort levels varied, with the prone position being the most comfortable, followed by right lateral, supine, and left lateral positions.", "population_specificity": "Preterm infants receiving NCPAP therapy.", "effective_dosage": "Not specified", "study_duration": "60 minutes per position, with stabilization for 15 minutes before measurements.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:32.026239+00:00"}
{"study_id": 53646, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether a lung recruitment maneuver before surfactant administration (IN-REC-SUR-E) reduced the need for mechanical ventilation in extremely preterm neonates compared to the standard IN-SUR-E technique.", "results_summary": "The IN-REC-SUR-E approach significantly reduced the need for mechanical ventilation within the first 72 hours of life (40% vs. 54%) without increasing adverse outcomes like mortality, pneumothorax, or severe intraventricular hemorrhage. The study suggests this method improves surfactant efficacy and supports non-invasive respiratory strategies.", "population_specificity": "Extremely preterm neonates (24+0 to 27+6 weeks' gestation) failing continuous positive airway pressure within the first 24 hours of life.", "effective_dosage": "Not specified", "study_duration": "Intervention effects were assessed over the first 72 hours of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:32.898921+00:00"}
{"study_id": 53645, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether administering oropharyngeal surfactant at birth reduces the rate of endotracheal intubation for respiratory failure in preterm infants within 120 hours of birth.", "results_summary": "The study suggests that supporting newborns with RDS using CPAP and reserving endotracheal surfactant for those who develop respiratory failure despite CPAP yields better results than intubating all infants for surfactant. However, the abstract does not provide specific outcome data from the trial.", "population_specificity": "Preterm infants born before 29 weeks gestational age with a plan to offer intensive care, excluding those with major congenital anomalies.", "effective_dosage": "120 mg vial for infants <26 weeks GA; 240 mg vial for infants 26-28 weeks GA.", "study_duration": "Intervention administered at birth, with outcomes assessed within 120 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:32.918325+00:00"}
{"study_id": 53648, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess whether isolated nasal surgery could improve CPAP tolerance in OSA patients with nasal obstruction.", "results_summary": "Nasal surgery significantly reduced nasal resistance and improved CPAP tolerance in 40 out of 43 previously intolerant patients, though it did not change AHI. Surgery also increased oxygen saturation nadir and shortened apnea-hypopnea duration.", "population_specificity": "OSA patients with AHI \u2265 20 and symptomatic nasal obstruction who were CPAP-intolerant (n=43 surgery group, n=43 matched controls).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:33.988395+00:00"}
{"study_id": 53650, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to provide evidence-based recommendations for the use of Continuous Positive Airway Pressure (CPAP) in pediatric patients with acute respiratory distress.", "results_summary": "The study discusses the appropriate use of CPAP in pediatric patients with respiratory distress, including contraindications and complications, but does not provide specific efficacy data.", "population_specificity": "Pediatric patients with respiratory distress secondary to asthma and bronchiolitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:36.814600+00:00"}
{"study_id": 53634, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Continuous Positive Airway Pressure (CPAP) on pulmonary hemodynamics in patients with sleep-related breathing disorders (SBDs) and pulmonary hypertension (PH), including its therapeutic benefits and potential risks.", "results_summary": "The study found that CPAP is effective in treating obstructive sleep apnoea syndrome (OSAS) in patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH), potentially preventing worsening of PH. However, adaptive servo-ventilation for central apnoea and Cheyne-Stokes respiration in chronic right-heart failure patients was cautioned due to potential serious adverse effects.", "population_specificity": "Patients with sleep-related breathing disorders (SBDs), including obstructive sleep apnoea syndrome (OSAS), obesity hypoventilation syndrome (OHS), overlap syndrome (COPD with OSA), pulmonary arterial hypertension (PAH), and chronic thromboembolic pulmonary hypertension (CTEPH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:37.844868+00:00"}
{"study_id": 53649, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to identify predictors of nasal high-flow treatment success in newborn infants with respiratory distress in nontertiary special care nurseries.", "results_summary": "The study found that 80% of infants experienced treatment success with nasal high-flow, predicted weakly by higher gestational age and lower supplemental oxygen requirement. The predictive model had modest accuracy (AUC 0.63).", "population_specificity": "Newborn infants \u226531 weeks gestation, birth weight \u22651200 g, with respiratory distress in Australian nontertiary special care nurseries.", "effective_dosage": "Not specified", "study_duration": "72 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:38.084498+00:00"}
{"study_id": 53652, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if CPAP treatment improves exercise capacity (measured by V\u0307O\u2082 peak, V\u0307O\u2082 max, and anaerobic threshold) in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found a small increase in V\u0307O\u2082 peak after CPAP treatment but no significant changes in V\u0307O\u2082 max or anaerobic threshold. The authors noted a lack of high-quality studies and recommended further research.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:40.113473+00:00"}
{"study_id": 53651, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare the management and short-term outcomes of nasal continuous positive airway pressure (nCPAP) in tertiary and non-tertiary centers for neonates \u226532 weeks' gestation with acute respiratory distress.", "results_summary": "Neonates in non-tertiary centers received more conservative nCPAP management with different equipment and had lower Apgar scores at five minutes, along with a higher incidence of air leaks. However, short-term outcomes were otherwise similar between tertiary and non-tertiary centers, with tertiary centers more likely to administer nCPAP to term babies for <24 hours.", "population_specificity": "Neonates \u226532 weeks' gestation with acute respiratory distress in tertiary and non-tertiary centers.", "effective_dosage": "Not specified", "study_duration": "Not specified (study period was 2010-2014)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:42.003417+00:00"}
{"study_id": 53656, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Continuous Positive Airway Pressure (CPAP) therapy on oxidative stress, inflammation, and endothelial dysfunction in patients with Obstructive Sleep Apnea (OSA).", "results_summary": "CPAP therapy demonstrated beneficial effects on vascular function and reduced pro-inflammatory markers in OSA patients, improving oxidative stress, inflammation, and endothelial dysfunction. Nocturnal intermittent hypoxia was significantly associated with these adverse effects, which CPAP mitigated.", "population_specificity": "Patients with Obstructive Sleep Apnea (OSA) diagnosed according to American Academy of Sleep Medicine guidelines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:42.726325+00:00"}
{"study_id": 53654, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the long-term effects of different PAP strategies (fixed C-PAP, automatic, and bilevel pressure) on renal function and survival in OSA patients.", "results_summary": "The study found a significant reduction in creatinine serum levels after 3 years of fixed C-PAP treatment, suggesting preserved kidney function. Long-term renal function and 10-year survival were evaluated, with results stratified by PAP treatment type and compliance.", "population_specificity": "Adults (\u226518 years) with OSA syndrome, diagnosed per AASM guidelines, from a single-center database.", "effective_dosage": "Not specified", "study_duration": "Measurements taken at baseline, 3 years, and 8 years post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:43.616715+00:00"}
{"study_id": 53653, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of ravulizumab plus best supportive care (BSC) compared to BSC alone on survival and clinical outcomes in patients with severe COVID-19, including those requiring mechanical ventilation or non-invasive support like Continuous Positive Airway Pressure (CPAP).", "results_summary": "The abstract does not provide specific results regarding CPAP's effects, as the focus is on ravulizumab's impact on survival, organ failure, and other secondary outcomes in severe COVID-19 patients.", "population_specificity": "Adults \u226518 years with severe COVID-19 requiring hospitalization, including those on mechanical ventilation (invasive or non-invasive, such as CPAP/BiPAP).", "effective_dosage": "Not applicable (CPAP was part of standard care, not the intervention).", "study_duration": "Not specified for CPAP (study duration was 3 months total).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:43.802619+00:00"}
{"study_id": 53657, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy of non-invasive continuous positive airway pressure (NI-CPAP) in treating mild to moderate ARDS secondary to SARS-CoV-2 and assess lung ultrasound's role in monitoring treatment response.", "results_summary": "NI-CPAP improved PaO2/FiO2 ratios in 10 out of 18 patients after one hour, but only half showed detectable lung aeration improvement via ultrasound, suggesting other mechanisms like blood redistribution may contribute to efficacy.", "population_specificity": "18 patients with mild to moderate ARDS secondary to SARS-CoV-2 infection.", "effective_dosage": "Not specified", "study_duration": "1 hour", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:46.816300+00:00"}
{"study_id": 53658, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to analyze the introduction and efficacy of less invasive surfactant administration (LISA) using different forms of continuous positive airway pressure (CPAP), including nCPAP, NIPPV, and BiPAP, in neonatal care.", "results_summary": "The study found that LISA procedures were mostly rated as \"easy/very easy\" after training, with a 6-fold increase in adoption rates. Efficacy was similar across nCPAP, NIPPV, and BiPAP, with no significant difference in intubation rates (22.4% vs. 24.5%).", "population_specificity": "Preterm infants in 31 tertiary neonatal centers.", "effective_dosage": "Not specified (procedure-based intervention).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:48.153546+00:00"}
{"study_id": 53659, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the prognostic impact of CPAP treatment in patients with varying severities of obstructive sleep apnea (OSA), particularly its effectiveness in preventing cardiovascular events.", "results_summary": "CPAP was effective in preventing cardiovascular disease in severe OSA patients, but patients with very severe OSA (AHI>55events/h) still had a significantly higher event rate, suggesting CPAP alone might be insufficient for this subgroup. The very severe OSA group had the highest hazard ratio for adverse outcomes compared to other risk factors.", "population_specificity": "91 OSA patients divided into mild/moderate (AHI<30events/h), severe (AHI 30-55events/h), and very severe (AHI>55events/h) groups.", "effective_dosage": "Not specified", "study_duration": "5-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:49.044596+00:00"}
{"study_id": 53660, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if a non-invasive oscillating device (NIOD) performed by non-specialized personnel is non-inferior to standard chest physiotherapy (CPT) for mechanically ventilated COVID-19 patients.", "results_summary": "The study did not report specific results as recruitment had not yet started, but it planned to compare oxygenation levels before and after NIOD and CPT interventions.", "population_specificity": "Mechanically ventilated COVID-19 patients admitted to two ICUs (one pediatric and one adult) in Canadian Academic Hospitals.", "effective_dosage": "Not specified", "study_duration": "Alternating 3-hour intervals for NIOD and CPT over 3 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:50.427184+00:00"}
{"study_id": 53661, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if nasal high-frequency percussive ventilation (nHFPV) was noninferior to nasal continuous positive airway pressure (nCPAP) in maintaining regional cerebral oxygen saturation (rScO\u2082) in newborns with respiratory distress.", "results_summary": "The study found that cerebral oxygenation via nHFPV was not inferior to nCPAP in newborns with gestational age \u226533 weeks, with no significant difference in mean rScO\u2082 between the two treatments.", "population_specificity": "Newborns of gestational age \u226533 weeks with persistent respiratory distress after 10 minutes of life.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:50.773015+00:00"}
{"study_id": 53663, "supplement_id": 1048, "safety_score": "30", "efficacy_score": 70, "quality_score": 60, "study_goal": "To assess the long-term impact of positive airway pressure mask use on midface growth in children and adolescents.", "results_summary": "Four out of five studies showed midface hypoplasia with long-term nasal positive airway pressure use in children/adolescents, while one study found no difference compared to controls.", "population_specificity": "Children and adolescents (growing individuals)", "effective_dosage": "Not Assessed", "study_duration": "Long-term (specific duration not mentioned)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:51.039561+00:00"}
{"study_id": 53664, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of nasal continuous positive airway pressure (NCPAP) versus bi-level CPAP in treating transient tachypnea of the newborn (TTN).", "results_summary": "Bi-level CPAP reduced the rate of noninvasive ventilation (NIV) failure and intubation compared to NCPAP in infants with TTN. The intubation rate was significantly higher in the NCPAP group (15/75) than in the bi-level CPAP group (6/76).", "population_specificity": "Late preterm and term infants (\u226534 gestational weeks, birth weight \u22652,000 g) diagnosed with TTN.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:53.151008+00:00"}
{"study_id": 53662, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy and immediate outcomes of bubble-continuous positive airway pressure (bCPAP) compared to oxygen therapy in preterm babies with respiratory distress syndrome (RDS) in a resource-limited setting.", "results_summary": "The study found that bCPAP improved survival rates (77.3% vs. 47.8%) and reduced the risk of death by 52% compared to oxygen therapy, though nasal bleeding was more common in the bCPAP group. The median treatment duration was similar between groups, but bCPAP showed a clinically meaningful survival benefit.", "population_specificity": "Preterm babies admitted to a neonatal care unit in Tanzania with signs of respiratory distress.", "effective_dosage": "Not specified", "study_duration": "Median treatment duration was 2 days (range 0-5 days for bCPAP, 0-16 days for oxygen therapy).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:53.472965+00:00"}
{"study_id": 53666, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to compare the success of progressive pressure wean versus sudden wean for discontinuation of NCPAP in preterm infants.", "results_summary": "Sudden wean was associated with a lower postmenstrual age at successful weaning but a lower rate of success on the first attempt compared to pressure wean. Pressure wean showed higher success at first attempt but no significant differences in length of stay or bronchopulmonary dysplasia.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:56.059322+00:00"}
{"study_id": 53665, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of high-dose versus standard-dose LMWH (Enoxaparin) in preventing clinical worsening (including the need for CPAP or NIV) in hospitalized COVID-19 patients not requiring invasive mechanical ventilation.", "results_summary": "The abstract does not provide specific results regarding CPAP's effects, as the study focuses on comparing LMWH dosing regimens. CPAP is listed as an outcome measure (clinical worsening) but not as an intervention being tested.", "population_specificity": "Hospitalized COVID-19 patients (aged 18-80) with severe pneumonia and coagulopathy, not requiring invasive mechanical ventilation.", "effective_dosage": "Not applicable (CPAP was an outcome, not an intervention).", "study_duration": "Until hospital discharge or occurrence of primary outcomes.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:57.065447+00:00"}
{"study_id": 53667, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the feasibility and effect on gas exchange of prone positioning in awake, non-intubated patients with COVID-19-related pneumonia receiving Continuous Positive Airway Pressure.", "results_summary": "Prone positioning was feasible and effective in rapidly improving blood oxygenation in awake patients with COVID-19-related pneumonia requiring oxygen supplementation, with the effect maintained after resupination in half of the patients.", "population_specificity": "Patients aged 18-75 years with confirmed COVID-19-related pneumonia receiving supplemental oxygen or non-invasive Continuous Positive Airway Pressure.", "effective_dosage": "Not specified", "study_duration": "Minimum of 3 hours in prone position", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:57.599918+00:00"}
{"study_id": 53669, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to test the diagnostic accuracy of predicting CPAP failure in premature infants with respiratory distress syndrome (RDS) by integrating oxygen saturation (SpO2).", "results_summary": "The abstract does not provide specific results regarding CPAP's effects, only stating the study's aim.", "population_specificity": "Premature infants with respiratory distress syndrome (RDS).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:58.128865+00:00"}
{"study_id": 53670, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) in managing hypertension associated with obstructive sleep apnea (OSA).", "results_summary": "The study suggests that CPAP is a major treatment option for OSA, which can help control blood pressure, particularly in severe cases, by addressing hypoxia-induced mechanisms like sympathetic nerve activation and endothelial dysfunction.", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly those with secondary hypertension.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:58.782616+00:00"}
{"study_id": 53668, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Continuous Positive Airway Pressure (CPAP) in managing acute respiratory failure (ARF) in COVID-19 patients, particularly in comparison to other respiratory support methods.", "results_summary": "The study found that CPAP can be used safely without increased infection risk to staff if proper PPE is provided. It is effective in managing hypoxemia in ARF patients when criteria for intubation are not met, though rapid deterioration under CPAP necessitates continuous monitoring and readiness for intubation.", "population_specificity": "COVID-19 patients with acute respiratory failure (ARF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:29:59.012203+00:00"}
{"study_id": 53671, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to examine the relationship between obstructive sleep apnea syndrome (OSAS) and depressive/cognitive symptoms, and the effect of OSAS treatment (including CPAP) on psychiatric symptoms.", "results_summary": "CPAP treatment showed partial recovery in some cognitive functions (e.g., attention) but deficits caused by untreated OSA may be irreversible. There is significant overlap between OSA and depressive/anxious symptoms.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and associated psychiatric comorbidities (e.g., depressive symptoms, cognitive dysfunction).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:01.675808+00:00"}
{"study_id": 53672, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) could help mitigate sleep walking (SW) and sleep-related eating (SRE) in patients with comorbid obstructive sleep apnea (OSA) taking atypical antipsychotics.", "results_summary": "CPAP, when used for comorbid OSA treatment, contributed to remission of SW/SRE in all cases where it was applied, alongside other measures like dosage reduction or medication switching. The abstract suggests CPAP may be effective in managing these parasomnias when OSA is present.", "population_specificity": "Patients with SW/SRE associated with atypical antipsychotic use, particularly those with comorbid OSA (mean age 44.8 years, 75% male).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:03.144692+00:00"}
{"study_id": 53673, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of continuous positive airway pressure (CPAP) versus mandibular advancement device (MAD) in treating obstructive sleep apnea (OSA).", "results_summary": "CPAP significantly reduced apnea hypopnea index (AHI) and percentage of stage 1 and 2 sleep compared to MAD, but also decreased SF-36-social function score. No significant difference was found in Epworth sleepiness scale scores between the two treatments.", "population_specificity": "Patients with obstructive sleep apnea (249 in CPAP group, 247 in MAD group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:04.997100+00:00"}
{"study_id": 53674, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of two surfactant administration methods (LISA and LPPSA) on respiratory outcomes in preterm infants with RDS, focusing on avoiding high-pressure ventilation.", "results_summary": "The study suggests that LISA may reduce respiratory morbidity, particularly BPD, by maintaining continuous positive airway pressure and avoiding complications from intubation and high-pressure ventilation. However, robust evidence is lacking, and the trial aims to provide clearer data.", "population_specificity": "Preterm infants with gestational age between 25-32 weeks and respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:05.359291+00:00"}
{"study_id": 53675, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if using the WatchPAT device for diagnosing OSA reduces time to diagnosis and treatment with Continuous Positive Airway Pressure compared to traditional PSG, and to assess the cost-benefit of this approach.", "results_summary": "The study found that patients using WatchPAT had significantly shorter times to diagnosis (21 vs. 79.8 days) and treatment (46.3 vs. 118.4 days) compared to PSG, with cost savings of $1179.50 per patient.", "population_specificity": "Patients undergoing diagnostic sleep studies in a tertiary healthcare setting from 2014 to 2017.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:06.261457+00:00"}
{"study_id": 53676, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to summarize current evidence on the upper airway volume increase in OSA patients treated with oral appliances (OAs), not Continuous Positive Airway Pressure.", "results_summary": "The meta-analysis found that OAs significantly increased upper airway volume (1.95 cm\u00b3) and reduced AHI, with the velopharynx showing the greatest improvement. Post-treatment AHI was either <10 events/hour or reduced by >50% from baseline.", "population_specificity": "291 patients with obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:06.404005+00:00"}
{"study_id": 53677, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to study the association between NAFLD and OSA and evaluate the efficacy of CPAP treatment in this context.", "results_summary": "The study found a potential link between OSA and NAFLD severity, suggesting that systematic polysomnography in NAFLD patients could help in early treatment. However, specific efficacy data on CPAP treatment was not detailed in the abstract.", "population_specificity": "NAFLD patients with or without OSA, mean age 42-58 years, BMI 24.0-49.9 kg/m\u00b2, and varying proportions of males (21%-87.9%).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:07.582159+00:00"}
{"study_id": 53679, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether elevated serum periostin levels could indicate severe OSA with comorbidities and assess the effects of CPAP treatment on these levels.", "results_summary": "CPAP treatment significantly reduced serum periostin and urinary albumin levels in patients with severe OSA and high periostin levels, suggesting potential benefits for managing comorbidities like albuminuria.", "population_specificity": "96 patients diagnosed with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:08.993911+00:00"}
{"study_id": 53678, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the prevalence, associated factors, and impact of moderate to severe sleep-disordered breathing (SDB) on survival in lung transplant patients, as well as the effect of CPAP compliance on survival.", "results_summary": "CPAP-compliant SDB patients showed better survival compared to SDB patients without CPAP treatment, though SDB itself did not impact mortality or chronic lung allograft dysfunction prevalence. The study found a high prevalence of SDB post-lung transplantation, particularly in certain patient groups.", "population_specificity": "Lung transplant patients (n = 219), predominantly older males with higher BMI and neck circumference, particularly those with chronic obstructive pulmonary disease/emphysema or pulmonary fibrosis.", "effective_dosage": "Not specified", "study_duration": "Polysomnography was performed 1 year post-LTX; CPAP intervention duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:09.459810+00:00"}
{"study_id": 53682, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The study does not focus on Continuous Positive Airway Pressure (CPAP); it examines a severe congenital CMV infection case in a neonate born to a CMV-immune mother.", "results_summary": "The study does not report any findings related to Continuous Positive Airway Pressure (CPAP).", "population_specificity": "A neonate with severe congenital CMV infection.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:12.414055+00:00"}
{"study_id": 53680, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify gene transcription associations with Sleep Disordered Breathing (SDB) and hypoxemia during sleep and assess their response to Continuous Positive Airway Pressure (CPAP) treatment.", "results_summary": "CPAP treatment increased the expression of genes (CD1D and RAB20) associated with low oxygen saturation during sleep and partially reversed alterations in gene expression and transcriptional programs linked to SDB. Immunity and inflammation pathways were down-regulated following CPAP treatment.", "population_specificity": "Participants with moderate or severe obstructive sleep apnea (OSA) from the Heart Biomarkers In Apnea Treatment (HeartBEAT) trial, and broader cohorts (Framingham Offspring Study and Multi-Ethnic Study of Atherosclerosis).", "effective_dosage": "Not specified", "study_duration": "Three months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:12.611690+00:00"}
{"study_id": 53681, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers reviewed existing literature to evaluate the etiology, clinical presentation, treatment, and complications of pneumoparotid, including cases related to continuous positive airway pressure (CPAP).", "results_summary": "CPAP was identified as an iatrogenic cause of pneumoparotid in 33.4% of iatrogenic cases, but the abstract does not detail CPAP's specific effects or outcomes. The study primarily focused on broader etiologies and treatments of pneumoparotid.", "population_specificity": "Patients with pneumoparotid, including those with iatrogenic causes such as CPAP use.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:13.876744+00:00"}
{"study_id": 53683, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to summarize recent advances in airway management, including the use of nasal continuous positive airway pressure (CPAP) masks.", "results_summary": "The abstract mentions nasal CPAP as a form of noninvasive ventilation but does not provide specific findings on its effects.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:13.897271+00:00"}
{"study_id": 53684, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether combining a weight-loss Mediterranean diet/lifestyle intervention with standard CPAP care for OSA leads to greater cardiometabolic improvements compared to standard care alone.", "results_summary": "The abstract does not provide specific results regarding CPAP's effects, but the study compares combined intervention (diet/lifestyle + CPAP) to standard CPAP care alone for cardiometabolic outcomes.", "population_specificity": "187 overweight adults with polysomnography-diagnosed moderate-to-severe obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:14.395653+00:00"}
{"study_id": 53685, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "To compare the effectiveness of nasal continuous positive airway pressure (NCPAP) delivered via nasal masks (NM) versus binasal prongs (BNP) in reducing intubation rates within 72 hours in preterm infants.", "results_summary": "NCPAP via NM significantly reduced intubation rates within 72 hours, nasal trauma, surfactant treatment, and bronchopulmonary dysplasia compared to BNP, though it increased NCPAP duration. No significant differences were found in secondary outcomes.", "population_specificity": "Preterm infants with respiratory distress syndrome.", "effective_dosage": "Not specified", "study_duration": "72 hours (primary outcome)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:15.676191+00:00"}
{"study_id": 53687, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of nasal CPAP combined with surfactant therapy in reducing RDS-related deaths in resource-restricted regions of sub-Saharan Africa.", "results_summary": "The study found that combining oxygen, nasal CPAP, and surfactant therapy could prevent 42% of RDS-related deaths in sub-Saharan Africa, highlighting its potential despite financial constraints. Data from South Africa's Western Cape province illustrated the impact of RDS management strategies in resource-limited settings.", "population_specificity": "Very-low-birth-weight infants in resource-restricted regions of sub-Saharan Africa, specifically the Western Cape province, South Africa.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:18.217692+00:00"}
{"study_id": 53686, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effects of CPAP therapy on reducing atrial fibrillation (AF) recurrence in patients with obstructive sleep apnea (OSA) under rhythm control strategies, considering factors like age, weight, and follow-up duration.", "results_summary": "CPAP therapy significantly reduced AF recurrence (RR = 0.63), with stronger benefits observed in patients younger than 60, those with BMI < 30, and shorter follow-up periods (\u2264 1 year). The study concluded that CPAP compliance should be recommended alongside weight control and early AF intervention.", "population_specificity": "OSA patients with AF, stratified by age (<60 vs. \u226560), BMI (<30 vs. \u226530), and follow-up duration (\u22641 year vs. >1 year).", "effective_dosage": "Not specified", "study_duration": "Varied by study (follow-up periods ranged up to >1 year)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:19.372925+00:00"}
{"study_id": 53689, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the association between neonatal characteristics (e.g., gestational age, use of continuous positive airway pressure) and the type, duration, and severity of cardiorespiratory events in preterm infants.", "results_summary": "The study found that the incidence of combined desaturation and bradycardia was higher with the use of continuous positive airway pressure (CPAP), suggesting CPAP may influence event severity. However, CPAP was not directly evaluated for efficacy in reducing events, only its correlation with event types.", "population_specificity": "Preterm infants with gestational age <32 weeks and/or birth weight <1500 g.", "effective_dosage": "Not specified", "study_duration": "Observational period covered the first 72 hours of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:21.673955+00:00"}
{"study_id": 53690, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Continuous Positive Airway Pressure (CPAP) in improving sleep, cardiovascular outcomes, quality of life, and mortality in patients with heart failure with reduced ejection fraction and predominant central sleep apnea.", "results_summary": "CPAP demonstrated positive short-term outcomes on sleep, cardiovascular health, and quality of life at 3 months, but longer-term cardiovascular and mortality data did not show significant benefits.", "population_specificity": "Patients with heart failure with reduced ejection fraction (HFrEF \u226450%) and predominant central sleep apnea (AHI \u226510).", "effective_dosage": "Not specified", "study_duration": "Short-term (3 months) and longer-term (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:22.168817+00:00"}
{"study_id": 53691, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate microbiological contamination of catheters used for less invasive surfactant administration (LISA) via the nasal route in infants with respiratory distress syndrome (RDS) and its association with postnatal age.", "results_summary": "The study found that 20% of catheter tips showed positive microbial cultures, with contamination risk increasing with postnatal age (10% at <4h, 20% at 4-18h, 40% at >18h). Earlier surfactant administration might reduce contamination risk, though clinical relevance remains unclear.", "population_specificity": "Premature infants with respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:22.533872+00:00"}
{"study_id": 53692, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the acceptability of bubble continuous positive airway pressure (bCPAP) and low-flow oxygen among mothers of children who received either therapy, focusing on community perceptions and maternal attitudes.", "results_summary": "Community perceptions of oxygen and bCPAP were initially negative, with mothers fearing these treatments and delaying or avoiding them. However, after treatment, mothers became supportive of the therapy and would recommend it to others, regardless of the child's outcome.", "population_specificity": "Mothers of children aged 1 to 59 months with severe pneumonia and comorbidities (HIV-infection, HIV-exposure, malnutrition, or hypoxaemia) in Salima, Malawi.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:23.961698+00:00"}
{"study_id": 53693, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of invasive hypoglossal nerve stimulation (HNS) and transcutaneous electrical stimulation (TES) as alternatives to continuous positive airway pressure (CPAP) in treating obstructive sleep apnea (OSA).", "results_summary": "Both HNS and TES reduced OSA severity by a clinically relevant margin, with HNS showing significant symptom improvement. TES, while promising, requires further investigation as a non-invasive alternative.", "population_specificity": "Middle-aged (mean 56.9 \u00b1 5.5 years), overweight (BMI 29.1 \u00b1 1.5 kg/m\u00b2) individuals with moderate to severe OSA.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:24.795969+00:00"}
{"study_id": 53688, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the effects of anti-platelet therapy on arterial oxygenation and clinical outcomes in severe Covid-19 patients requiring helmet CPAP.", "results_summary": "Treated patients showed significant improvements in A-a O2 gradient and PaO2/FiO2 ratio, with most successfully weaned from CPAP after 3 days, unlike controls. No major adverse events were observed.", "population_specificity": "Severe Covid-19 patients with hypercoagulability, respiratory failure requiring CPAP, bilateral pulmonary infiltrates, and elevated D-dimer.", "effective_dosage": "Helmet CPAP (specific settings not detailed); tirofiban (25 \u03bcg/kg bolus, then 0.15 \u03bcg/kg/min for 48h), ASA (250 mg IV then 75 mg/day), clopidogrel (300 mg then 75 mg/day), fondaparinux (2.5 mg/day SC).", "study_duration": "48 hours for tirofiban infusion; 30 days for ASA/clopidogrel.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:25.613072+00:00"}
{"study_id": 53694, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether nonsynchronized nasal intermittent positive pressure ventilation (NS-NIPPV) reduces extubation failure compared to nasal continuous positive airway pressure (NCPAP) in very low birth weight infants with respiratory distress syndrome.", "results_summary": "The study found no significant difference in extubation failure rates between NS-NIPPV and NCPAP (32.1% vs. 32.4%). There were also no significant differences in adverse outcomes such as deaths, bronchopulmonary dysplasia, or intraventricular hemorrhage between the two groups.", "population_specificity": "Very low birth weight infants (mean birth weight 1,027 \u00b1 256 g, gestational age 27.8 \u00b1 1.9 weeks) with respiratory distress syndrome.", "effective_dosage": "Not specified", "study_duration": "Intervention assessed within 72 hours post-extubation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:27.897136+00:00"}
{"study_id": 53695, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) as the gold standard treatment for Obstructive Sleep Apnea (OSA) and explore alternative surgical interventions for CPAP failure cases.", "results_summary": "CPAP is effective as a first-line treatment for OSA by preventing pharyngeal collapse during sleep, but its compliance can be hindered by extrapharyngeal collapse and pharyngeal obstructions. For CPAP failure patients, multi-dimensional surgery (soft tissue, skeletal, or bariatric) is a viable alternative, with postoperative integrated therapy improving long-term outcomes.", "population_specificity": "Patients with Obstructive Sleep Apnea (OSA), including those with craniofacial anomalies or pathological obesity.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:28.756789+00:00"}
{"study_id": 53696, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of oral appliances versus Continuous Positive Airway Pressure (CPAP) in managing Obstructive Sleep Apnea (OSA).", "results_summary": "The study found that CPAP therapy is more predictable and effective in managing OSA compared to oral appliances, though oral appliances are recommended for patients who cannot tolerate CPAP. Measures to improve the predictability of oral appliance treatment were suggested.", "population_specificity": "Patients with Obstructive Sleep Apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:29.698952+00:00"}
{"study_id": 53698, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether CPAP therapy for obstructive sleep apnea (OSA) improves cough in patients with chronic unexplained cough.", "results_summary": "CPAP therapy significantly improved cough quality of life measures (Leicester Cough Questionnaire scores) compared to sham therapy, but no significant differences were observed in exhaled breath condensate markers of airway inflammation.", "population_specificity": "Patients with unexplained chronic cough (>2 months duration) and OSA.", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:30.032316+00:00"}
{"study_id": 53697, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to identify the causes of CPAP failure in OSA patients by assessing upper airway collapse patterns during DISE with CPAP therapy.", "results_summary": "The study found that 37% of patients had persistent anteroposterior collapse, 27% had a floppy epiglottis, and 17% had persistent complete concentric collapse, suggesting potential reasons for CPAP failure. In 10% of cases, no collapse was observed after CPAP administration.", "population_specificity": "30 patients diagnosed with OSA and CPAP failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:30.410259+00:00"}
{"study_id": 53699, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess the outcomes of COVID-19 in patients with IBD, including the need for respiratory therapies like Continuous Positive Airway Pressure (CPAP).", "results_summary": "Among 79 IBD patients with COVID-19, 9 (11%) required CPAP therapy. The study found that active IBD, older age, and comorbidities were associated with worse COVID-19 outcomes, but IBD treatments did not significantly impact the need for CPAP.", "population_specificity": "Patients with inflammatory bowel disease (IBD) and confirmed COVID-19 infection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:32.780145+00:00"}
{"study_id": 53700, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether sleep quality mediates the effects of Continuous Positive Airway Pressure (CPAP) treatment on work withdrawal behaviors in adults with obstructive sleep apnea.", "results_summary": "The study found that CPAP treatment improved sleep quality, which in turn reduced work withdrawal behaviors such as emotional exhaustion, cognitive distraction, work neglect, and partial absenteeism. The effects were observed at posttest (1 month after treatment) and follow-up (3 months later).", "population_specificity": "125 adults with potential sleep apnea, referred to a sleep disorders laboratory; 83 were diagnosed and received CPAP treatment.", "effective_dosage": "Not specified", "study_duration": "1 month initial treatment, with follow-up at 3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:33.754363+00:00"}
{"study_id": 53701, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the role of Continuous Positive Airway Pressure (CPAP) as the primary therapy for obstructive sleep apnea and highlight its relevance for otorhinolaryngologists.", "results_summary": "The abstract states that CPAP is the therapy of choice for most patients with obstructive sleep apnea, though alternative treatments are increasingly sought. It emphasizes the importance of sleep study application and interpretation for otorhinolaryngologists.", "population_specificity": "Patients with obstructive sleep apnea, particularly those seeking alternative treatments.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:34.693161+00:00"}
{"study_id": 53702, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether continuous positive airway pressure (CPAP) therapy significantly reduces subcutaneous adipose tissue (SAT) in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found no significant change in SAT before and after CPAP treatment in OSA patients (SMD = -0.02, 95% CI -0.25 to 0.2, p = 0.85). Subgroup analyses confirmed no impact from age, therapy duration, baseline BMI, or measurement method.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:36.825134+00:00"}
{"study_id": 53704, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the cognitive effects of CPAP treatment on patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found that CPAP treatment partially improved cognitive impairment, specifically attention and speed of information processing, in severe OSA patients, but no significant effects were observed in other cognitive domains or milder cases.", "population_specificity": "Patients with obstructive sleep apnea (OSA), particularly severe cases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:37.211425+00:00"}
{"study_id": 53703, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Continuous Positive Airway Pressure (CPAP) is more effective than a non-rebreather mask (NRB) in reducing carboxyhemoglobin (SpCO) levels in patients with carbon monoxide (CO) poisoning.", "results_summary": "CPAP significantly lowered SpCO levels faster than NRB at 30, 60, and 90 minutes of treatment, with the fastest decline occurring in the first 30 minutes. CPAP also significantly reduced the COHb half-life compared to NRB.", "population_specificity": "Patients with CO poisoning (45 total: 24 in NRB group, 21 in CPAP group).", "effective_dosage": "Not specified (treatment administered for at least 90 minutes).", "study_duration": "At least 90 minutes.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:38.411469+00:00"}
{"study_id": 53705, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to assess the benefits and harms of non-invasive respiratory support, including CPAP, for managing transient tachypnea of the newborn.", "results_summary": "CPAP reduced the duration of tachypnea compared to free oxygen but did not significantly improve primary outcomes like the need for mechanical ventilation or pneumothorax. Evidence was limited and of low quality, making it difficult to determine CPAP's safety or efficacy conclusively.", "population_specificity": "Infants born at 34 weeks' gestational age or more and less than three days of age with transient tachypnea of the newborn.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:39.254860+00:00"}
{"study_id": 53706, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of short- and long-term CPAP therapy on nocturnal blood pressure fluctuations, nocturnal blood pressure, and arterial stiffness in patients with coexisting cardiovascular diseases and obstructive sleep apnea.", "results_summary": "CPAP therapy significantly reduced the frequency of nocturnal blood pressure fluctuations, lowered maximum systolic blood pressure by 9 mmHg after the first night, and further decreased average nocturnal systolic blood pressure by 10 mmHg after 6 months. It also reduced arterial stiffness, with effects observable immediately and strengthening over time.", "population_specificity": "Patients with coexisting cardiovascular diseases and obstructive sleep apnea (CVD/OSA).", "effective_dosage": "Not specified", "study_duration": "First night and 6 months of CPAP therapy", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:39.621933+00:00"}
{"study_id": 53707, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers sought to determine whether long-term CPAP treatment improves glycemic control and reduces diabetes risk in patients with cardiovascular disease and obstructive sleep apnea.", "results_summary": "The study found no evidence that CPAP therapy over several years affects glycemic control in patients with diabetes or prediabetes or reduces diabetes risk compared to standard care. A potential differential effect by sex was noted but requires further investigation.", "population_specificity": "Patients with established cardiovascular disease and obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 4.3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:41.933546+00:00"}
{"study_id": 53708, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) therapy affects subcutaneous adipose tissue (SAT) in patients with obstructive sleep apnea (OSA).", "results_summary": "The meta-analysis found no significant change in SAT after CPAP treatment (SMD = -0.014, 95% CI = -0.161 to 0.133, p = 0.896), with no predictors influencing this outcome.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:42.796912+00:00"}
{"study_id": 53710, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effectiveness of educational, supportive, behavioral, or mixed interventions in encouraging CPAP use among adults prescribed the therapy for obstructive sleep apnea (OSA).", "results_summary": "Behavioral interventions significantly increased CPAP usage (1.31 hours/night) and adherence (\u22654 hours/night), while supportive interventions modestly improved usage (0.70 hours/night). Educational and mixed interventions showed uncertain benefits due to very low-certainty evidence.", "population_specificity": "CPAP-na\u00efve adults with OSA and excessive daytime sleepiness (baseline Epworth Sleepiness Scale scores indicated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:45.330501+00:00"}
{"study_id": 53709, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to assess the feasibility and tolerance of NeuroPAP, a new non-invasive ventilation mode adjusting pressure support proportionally to diaphragm electrical activity, in preterm infants, and its impact on ventilation pressure and Edi.", "results_summary": "NeuroPAP was well tolerated and delivered during 100% of the planned period, with 83% of breaths well synchronized compared to 9% during NIPPV. It allowed transient PEEP adaptation in response to diaphragm activity changes.", "population_specificity": "Stable preterm infants (born at 28.0\u00b11.0 weeks) ventilated with non-invasive positive pressure ventilation (NIPPV).", "effective_dosage": "NeuroPAP with minimal pressure similar to NIPPV PEEP (60 min), then reduced by 2 cmH2O (60 min).", "study_duration": "90 minutes (30 min NIPPV, 60 min NeuroPAP).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:46.621469+00:00"}
{"study_id": 53711, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of CPAP for cardiovascular prevention in patients with obstructive sleep apnea (OSA) and increased cardiovascular risk.", "results_summary": "The study found no significant improvement in major cardiovascular events, mortality, myocardial infarction, unstable angina, stroke, atrial fibrillation, or heart failure with CPAP therapy. Subgroup and meta-regression analyses also showed no effect on these outcomes.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and increased cardiovascular risk (5,817 participants across 8 RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:46.675940+00:00"}
{"study_id": 53713, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to develop a qualitative phenotyping model for obstructive sleep apnea (OSA) patients using clinical polysomnography (PSG), OSA severity, and therapeutic CPAP levels.", "results_summary": "The study proposed a qualitative phenotyping model for OSA based on clinical PSG, OSA severity, and CPAP therapeutic levels, suggesting its utility for sleep specialists and customized OSA treatment.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:47.076589+00:00"}
{"study_id": 53712, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the frequency of clinical signs of temporomandibular disorder (TMD) pain and mandibular function impairment between mandibular advancement device (MAD) and nasal continuous positive airway pressure (nCPAP) therapies in obstructive sleep apnea (OSA) patients.", "results_summary": "The study found no significant differences in the low frequency of clinical signs of TMD pain or mandibular function impairment between MAD, nCPAP, and placebo groups after 6 months of treatment. Both therapies showed similar, minimal impact on TMD-related outcomes.", "population_specificity": "64 mild to severe OSA patients (average age 52.0 \u00b1 9.6 years).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:48.012617+00:00"}
{"study_id": 53714, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of high flow nasal cannula (HFNC) compared to standard oxygen therapy (SOT) and nasal continuous positive airway pressure (nCPAP) in infants with bronchiolitis.", "results_summary": "HFNC is a safe respiratory support option positioned between SOT and nCPAP, but it does not significantly reduce the duration of oxygen need or hospital admission. The review summarizes data from prospective RCTs to guide clinical use.", "population_specificity": "Infants with bronchiolitis and hypoxemia.", "effective_dosage": "Up to 2 L/min/kg body weight via nasal prongs.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:48.830843+00:00"}
{"study_id": 53715, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to review the molecular pathways contributing to cardiometabolic consequences of intermittent hypoxia in obstructive sleep apnoea and assess the limitations of Continuous Positive Airway Pressure (CPAP) in addressing these comorbidities.", "results_summary": "CPAP is highly effective at improving symptoms and quality of life in obstructive sleep apnoea but has limited effect on associated cardiometabolic comorbidities. The study highlights intermittent hypoxia as a key mechanism underlying these complications, involving pathways like sympathetic activation, inflammation, oxidative stress, and mitochondrial dysfunction.", "population_specificity": "Patients with obstructive sleep apnoea and associated cardiometabolic comorbidities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:50.309122+00:00"}
{"study_id": 53716, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the link between sleep breathing disorders and arrhythmias and assess the potential impact of OSA treatment (such as CPAP) on reducing arrhythmia recurrence.", "results_summary": "The study highlights a strong association between sleep apnea and arrhythmias, suggesting that treating OSA (e.g., with CPAP) may reduce arrhythmia recurrence. It reviews pathophysiological mechanisms and discusses clinical implications for arrhythmia management.", "population_specificity": "Patients with sleep breathing disorders (e.g., OSA) and arrhythmias.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:50.719003+00:00"}
{"study_id": 53717, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the side effects associated with CPAP therapy in patients with obstructive sleep apnea (OSA) and their impact on treatment adherence.", "results_summary": "CPAP is highly efficacious in controlling OSA symptoms but has limited effectiveness due to low adherence caused by side effects. The review highlights the range of side effects associated with CPAP therapy, emphasizing their importance in patient initiation and continued care.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:53.247681+00:00"}
{"study_id": 53720, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of nasal obstruction in obstructive sleep apnea (OSA) and its impact on the effectiveness and tolerance of Continuous Positive Airway Pressure (CPAP) treatment.", "results_summary": "The study found that nasal obstruction contributes to OSA and interferes with CPAP tolerance. Medical and surgical treatments for nasal obstruction improved OSA severity, sleep symptoms, and CPAP tolerance.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and nasal obstruction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:55.159703+00:00"}
{"study_id": 53718, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to quantitatively evaluate whether CPAP therapy improves mood symptoms in patients with obstructive sleep apnoea syndrome (OSAS).", "results_summary": "The study found that CPAP treatment significantly improved depression in OSAS patients, with a pooled standard mean difference (SMD) of 0.31. Subgroup analysis showed greater effectiveness when CPAP use exceeded 4 hours per night (SMD = 0.38).", "population_specificity": "Patients with obstructive sleep apnoea syndrome (OSAS).", "effective_dosage": "Greater than 4 hours per night (subgroup analysis).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:55.329525+00:00"}
{"study_id": 53719, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of Continuous Positive Airway Pressure (CPAP) as part of a broader evidence-based perinatal critical strategy to improve neurodevelopmental outcomes in very preterm infants below 28 weeks gestational age.", "results_summary": "The abstract suggests that immediate respiratory support with CPAP in the delivery room is a critical strategy for improving outcomes in very preterm infants, though specific results regarding CPAP alone are not detailed. The overall approach, including CPAP, is presented as part of a comprehensive intervention to mitigate neurodevelopmental impairment.", "population_specificity": "Very preterm infants below 28 weeks gestational age.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:55.699865+00:00"}
{"study_id": 53721, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to assess whether postnatal corticosteroids (compared to placebo or other treatments) are effective and safe in treating transient tachypnoea of the newborn (TTN) in infants born at 34 weeks' gestational age or more.", "results_summary": "The study found no significant differences between inhaled corticosteroids (budesonide) and placebo in the need for nasal continuous positive airway pressure or mechanical ventilation. The quality of evidence was very low due to imprecision and indirectness.", "population_specificity": "Infants born at 34 weeks' gestational age or more, less than three days old, with TTN.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:57.032604+00:00"}
{"study_id": 53722, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "To assess the effectiveness and safety of diaphragm-triggered non-invasive respiratory support (NIV-NAVA) compared to other non-invasive modes (NIPPV, nCPAP, HFNC) in preterm infants.", "results_summary": "The study found no significant difference in failure rates between NIV-NAVA and NIPPV, but noted a reduction in maximum FiO\u2082 with NIV-NAVA and an increase in respiratory rate. The evidence was deemed very low certainty due to limited data.", "population_specificity": "Preterm infants (< 37 weeks' gestation), with a sub-group of infants < 1000 grams or < 28 weeks' corrected gestation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:30:57.973470+00:00"}
{"study_id": 53723, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to assess the effect of CPAP on glycated hemoglobin (HbA1c) levels in patients with type 2 diabetes and obstructive sleep apnea (OSA).", "results_summary": "CPAP therapy significantly reduced HbA1c levels by 1.1% after two months, particularly in patients with an initial HbA1c > 9%. The improvement was correlated with body weight, BMI, and baseline HbA1c levels.", "population_specificity": "Type 2 diabetic patients with OSA (30 participants, mean age 61.3 years, predominantly female).", "effective_dosage": "Compliance \u2265 4 hours/night (specific CPAP pressure not mentioned).", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:00.034510+00:00"}
{"study_id": 53724, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to examine the economic burden of excessive daytime sleepiness (EDS) in obstructive sleep apnea (OSA) patients, particularly focusing on the persistence of EDS despite continuous positive airway pressure (CPAP) treatment.", "results_summary": "The study found that persistent EDS in OSA patients following CPAP treatment occurs in 12%-65% of cases and is associated with indirect economic burdens like motor vehicle accidents, reduced work productivity, and diminished quality of life. Few studies detailed direct costs, highlighting a need for further research.", "population_specificity": "Adults with obstructive sleep apnea (OSA) experiencing excessive daytime sleepiness (EDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:00.100137+00:00"}
{"study_id": 53725, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of continuous positive airway pressure (CPAP) on pulse wave velocity and blood pressure in patients with type 2 diabetes and obstructive sleep apnea.", "results_summary": "CPAP treatment for 12 weeks did not significantly reduce pulse wave velocity or blood pressure in the studied population, though a minor significant change in office pulse wave velocity was observed between groups. No significant changes in ambulatory blood pressure were noted.", "population_specificity": "72 patients with type 2 diabetes and newly diagnosed obstructive sleep apnea from three Danish hospitals.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:01.369282+00:00"}
{"study_id": 53726, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the effects of morphine on obstructive sleep apnoea (OSA) and its potential to increase harm in individuals with OSA.", "results_summary": "The abstract suggests that opioids like morphine may worsen OSA by increasing upper airway collapsibility and respiratory depression, but it does not provide specific findings related to Continuous Positive Airway Pressure.", "population_specificity": "Individuals with obstructive sleep apnoea (OSA).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:02.793406+00:00"}
{"study_id": 53727, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of postoperative continuous positive airway pressure (CPAP) ventilation in reducing postoperative pulmonary complications (PPCs) in adult patients undergoing non-cardiac surgery.", "results_summary": "The study found low to moderate quality evidence suggesting that postoperative CPAP ventilation likely reduces the incidence of PPCs (risk ratio 0.49, 95% CI 0.24 to 0.99). Trial sequential analysis indicated insufficient data to conclusively support a 25% relative risk reduction for CPAP.", "population_specificity": "Adult patients undergoing non-cardiac surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:03.864803+00:00"}
{"study_id": 53729, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effectiveness of eHealth interventions in improving CPAP treatment adherence among adults with obstructive sleep apnea (OSA).", "results_summary": "eHealth interventions increased average nightly CPAP use by approximately half an hour compared to usual care, with no significant differences between add-on or replacement strategies, stand-alone or blended approaches, or automated versus guided interventions. Long-term effectiveness remains uncertain due to limited and mixed follow-up studies.", "population_specificity": "Adults with obstructive sleep apnea (OSA) (N=5429).", "effective_dosage": "Not specified", "study_duration": "1 to 6 months after baseline, depending on intervention length.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:05.785233+00:00"}
{"study_id": 53728, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if Continuous Positive Airway Pressure (CPAP) could reduce heart dose in left-sided breast cancer radiotherapy by altering lung and heart volume and position.", "results_summary": "CPAP increased median lung volume by 60% and decreased median heart volume by 12%, significantly reducing mean heart dose from 3.02 to 1.6Gy. While lung V20 decreased from 17.1 to 13.8 with CPAP, this change was not statistically significant.", "population_specificity": "24 women with left-sided breast cancer receiving adjuvant radiotherapy (median age 54 years; 70% breast-only radiation, 30% breast/chest wall and regional nodes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:06.149574+00:00"}
{"study_id": 53731, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the effect of CPAP adherence on cognition in older adults with mild obstructive sleep apnea and mild cognitive impairment.", "results_summary": "The study found that CPAP adherence significantly improved psychomotor/cognitive processing speed and increased the odds of cognitive improvement on clinical rating scales compared to nonadherent participants.", "population_specificity": "Older adults with mild obstructive sleep apnea and mild cognitive impairment.", "effective_dosage": "Average CPAP use of \u22654 hours per night for adherent group.", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:07.865798+00:00"}
{"study_id": 53732, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the accuracy and effectiveness of at-home versus in-laboratory APAP titration in estimating AHI, optimal pressure, and improvements in sleepiness, sleep quality, and quality of life, along with treatment adherence.", "results_summary": "The study found no clinical inferiority between home and laboratory APAP titration in terms of optimal pressure, residual events, treatment adherence, and improvements in subjective sleepiness, sleep quality, and quality of life after 3 months of treatment. A significant correlation was observed between PSG AHI and APAP AHI.", "population_specificity": "Patients with newly diagnosed obstructive sleep apnea syndrome (OSAS).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:09.524907+00:00"}
{"study_id": 53733, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to identify subgroups of patients with obstructive sleep apnoea (OSA) who respond best to continuous positive airway pressure (CPAP) or mandibular advancement devices (MADs) in terms of blood pressure (BP) reduction.", "results_summary": "CPAP and MADs were associated with modest BP reductions, with greater effects observed in patients aged <60 years, those with uncontrolled BP at baseline, and those with severe oxygen desaturations. The overall BP reduction was modest, but specific subgroups showed pronounced benefits.", "population_specificity": "Patients with obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:10.344989+00:00"}
{"study_id": 53734, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of Less Invasive Surfactant Administration (LISA) as an alternative when Continuous Positive Airway Pressure (CPAP) fails in treating premature infants with respiratory problems.", "results_summary": "The study found that LISA helps avoid mechanical ventilation in premature infants with respiratory distress syndrome (RDS) and improves outcomes, such as reducing bronchopulmonary dysplasia (BPD) and intracranial hemorrhage (ICH). However, the procedure still involves discomfort for infants, prompting ongoing research into less invasive techniques like surfactant nebulization.", "population_specificity": "Premature infants with respiratory problems, particularly those where CPAP fails.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:12.126348+00:00"}
{"study_id": 53730, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the clinical effects of LISA (via gastric tube) and INSURE (via tracheal intubation) techniques for administering pulmonary surfactant in premature infants with RDS under NCPAP.", "results_summary": "The LISA technique showed comparable safety and efficacy to INSURE, with more stable blood pressure and SpO2 during administration, but no significant differences in complications or outcomes between the two methods.", "population_specificity": "Premature infants aged 32 to 36 weeks with respiratory distress syndrome (RDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:14.499232+00:00"}
{"study_id": 53735, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) treatment reduces the risk of motor vehicle accidents (MVAs) in long-term users compared to untreated controls.", "results_summary": "The study found no significant change in MVA incidence after CPAP treatment. Among patients who had MVAs, higher BMI was the only differing baseline characteristic, which tended to increase further during treatment, while other factors like sleep study data or accident conditions showed no differences.", "population_specificity": "2060 patients (75.8% male, mean age 56.0 \u00b1 10.5 years) with obstructive sleep apnea (OSA), including CPAP-treated and untreated groups.", "effective_dosage": "Median CPAP usage was 6.4 hours/day.", "study_duration": "CPAP-treated patients were screened for MVAs for a median of 9.0 years before and after treatment; controls were screened for 6.5 years after discontinuation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:15.153894+00:00"}
{"study_id": 53736, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of CPAP treatment on aortic stiffness (measured by cf-PWV) in patients with resistant hypertension and moderate-severe obstructive sleep apnea.", "results_summary": "CPAP treatment did not significantly reduce aortic stiffness compared to the control group, but it may have prevented its progression, whereas the control group showed a significant increase in aortic stiffness. Subgroup analyses did not alter these findings.", "population_specificity": "Patients with resistant hypertension and moderate-severe obstructive sleep apnea (116 participants, 56 in CPAP group, 60 in control group).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:15.572222+00:00"}
{"study_id": 53738, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether treating obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) could improve posture/balance and reduce falls risk.", "results_summary": "The abstract suggests emerging evidence that CPAP improves gait in OSA patients, but no studies have examined its effect on posture/balance. The researchers postulate that OSA treatment may alleviate balance impairments and falls risk, but larger mechanistic studies and randomized control trials are needed.", "population_specificity": "Individuals with obstructive sleep apnea (OSA), particularly those at risk of falls due to balance impairments.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:16.657233+00:00"}
{"study_id": 53739, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the effects of sleep duration on cardiovascular health and evaluate the impact of CPAP treatment on survival in sleep apnea patients.", "results_summary": "CPAP treatment for sleep apnea was found to increase survival and mitigate cardiovascular risks, such as atherosclerosis and hypertension. Optimal sleep duration (6-8 hours) was associated with reduced mortality and major cardiovascular events.", "population_specificity": "Individuals with sleep apnea and those with suboptimal sleep duration.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:17.265703+00:00"}
{"study_id": 53740, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze the long-term effect of CPAP treatment on the incidence of cardiovascular events (CVE) in patients with resistant hypertension (RH) and moderate-severe obstructive sleep apnea (OSA).", "results_summary": "Non-adherence to CPAP showed a non-significant increase in total CVE incidence but a significant increase in cerebrovascular events and hypertensive crises, while coronary events showed an opposite trend. CPAP adherence did not significantly alter coronary event incidence.", "population_specificity": "Patients with moderate-severe OSA and resistant hypertension.", "effective_dosage": "At least 4 hours/day of CPAP use.", "study_duration": "58 months of follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:19.259837+00:00"}
{"study_id": 53741, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to examine the long-term effects of a tailored behavioral sleep medicine (BSM) intervention targeting physical activity and eating behavior in addition to CPAP treatment in patients with moderate to severe OSA combined with overweight and physical inactivity.", "results_summary": "The experimental group (CPAP + BSM intervention) showed a larger improvement in apnea-hypopnea index (AHI) at 18 months compared to the control group (CPAP alone). Improvement in OSA severity category occurred more frequently in the experimental group (36.7%) than the control group (6.7%).", "population_specificity": "Patients with moderate to severe obstructive sleep apnea (OSA), overweight (BMI: 34.5 \u00b1 5.0 kg/m\u00b2), and physical inactivity.", "effective_dosage": "Not specified", "study_duration": "18 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:22.958451+00:00"}
{"study_id": 53743, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether cloud-based sleep coaches (CBSC) providing live telephone contact could improve early adherence to Continuous Positive Airway Pressure (PAP) therapy compared to standard care.", "results_summary": "The study found that CBSC improved PAP adherence at 3 months, with significant increases in the percentage of days with \u22654 hours of use and overall nightly use. However, the percentage of participants achieving \u22654 hours of use on \u226570% of nights and improvements in sleepiness (ESS) did not differ between groups.", "population_specificity": "Veterans (250 participants, mean age ~55 years, with moderate to severe sleep apnea).", "effective_dosage": "Not specified (standard PAP therapy setup).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:23.880007+00:00"}
{"study_id": 53744, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the influence of OSA in morbidly obese patients and how CPAP treatment alters miRNA expression.", "results_summary": "The study will assess changes in circulating miRNA in morbidly obese patients with or without OSA and evaluate the impact of CPAP treatment, but specific results are not yet provided in the abstract.", "population_specificity": "Morbidly obese patients (BMI \u226535 kg/m\u00b2) with or without obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified", "study_duration": "Follow-up at baseline, 6 months pre-bariatric surgery, and 3, 6, and 12 months post-surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:24.159623+00:00"}
{"study_id": 53745, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effectiveness of different ventilation strategies, including Continuous Positive Airway Pressure (CPAP), in improving oxygenation and respiratory mechanics in obese patients undergoing bariatric surgery.", "results_summary": "CPAP 40 cmH2O + PEEP 15 cmH2O achieved better gas exchange and compliance compared to CPAP 40 cmH2O + PEEP 10 cmH2O. Recruitment maneuvers combined with PEEP also led to improved oxygenation and higher compliance.", "population_specificity": "Obese patients undergoing bariatric surgery.", "effective_dosage": "CPAP 40 cmH2O + PEEP 10 cmH2O or 15 cmH2O.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:24.581839+00:00"}
{"study_id": 53737, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to compare the effectiveness of nasal Continuous Positive Airway Pressure (nCPAP) and nasal Biphasic Positive Airway Pressure (nBiPAP) in treating respiratory distress syndrome (RDS) in term neonates.", "results_summary": "The study found that nBiPAP was more effective than nCPAP in reducing PaCO2 levels and FiO2 requirements while increasing pH and PaO2 levels after 1 hour of ventilation. No significant differences were observed in the length of non-invasive ventilation or hospital stay, though nCPAP had two intubations and one pneumothorax case.", "population_specificity": "Full-term neonates admitted to the NICU for respiratory distress at birth.", "effective_dosage": "Not specified", "study_duration": "1 hour of ventilation (monitored)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:25.119155+00:00"}
{"study_id": 53746, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether automatically adjusting continuous positive airway pressure (aCPAP) improves clinical outcomes after acute ischemic stroke or high-risk transient ischemic attack by reducing recurrent vascular events and enhancing functional recovery.", "results_summary": "The study is ongoing (Sleep SMART trial), so final results are not yet available. The abstract outlines the study design and objectives but does not report outcomes.", "population_specificity": "Adults with recent acute ischemic stroke or transient ischemic attack and confirmed obstructive sleep apnea without predominant central sleep apnea.", "effective_dosage": "Not specified (aCPAP use \u22654 hours per night during run-in).", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:25.151120+00:00"}
{"study_id": 53747, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of Continuous Positive Airway Pressure (CPAP) on cardiac mechanics in patients with Obstructive Sleep Apnea (OSA), including its impact on left and right ventricular structure and function.", "results_summary": "The study found that CPAP and weight reduction had favorable effects on left and right ventricular structure and function in OSA patients, with recent analyses confirming positive impacts on cardiac mechanics. Deterioration of ventricular mechanics occurs before functional and structural impairments, suggesting strain assessment could detect early cardiac changes.", "population_specificity": "Patients with Obstructive Sleep Apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:27.024320+00:00"}
{"study_id": 53748, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review recent literature on the importance of CPAP and antihypertensive treatment adherence in blood pressure control, particularly in hypertensive patients with obstructive sleep apnea.", "results_summary": "The study found that adherence to CPAP and antihypertensive drugs is crucial for improving sleep-related symptoms and modestly reducing blood pressure (2-2.5 mmHg), but adherence declines over time. Some patient phenotypes, such as those with severe sleep apnea or uncontrolled hypertension, showed better adherence and hypertensive effects.", "population_specificity": "Hypertensive patients, especially those with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:27.848394+00:00"}
{"study_id": 53749, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of sustained inflation versus standard therapies (intermittent positive pressure ventilation and continuous positive airway pressure) for preventing hospital mortality and morbidity in preterm infants.", "results_summary": "The study found no significant difference in the risk of death before hospital discharge between sustained inflation and standard therapies, though sustained inflation was associated with a higher risk of death in the first 2 days after birth. No differences were observed in secondary outcomes, and the evidence quality was rated as low due to bias and imprecision.", "population_specificity": "Preterm infants born at less than 37 weeks' gestation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:31.618743+00:00"}
{"study_id": 53750, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Continuous Positive Airway Pressure (CPAP) improves the success rate of atrial fibrillation (AF) treatment in patients with obstructive sleep apnea (OSA) and explored autonomic modulation as a potential alternative therapy.", "results_summary": "The abstract suggests that CPAP has shown relatively low compliance in OSA patients, and its efficacy in improving AF treatment success remains controversial. Autonomic modulation is proposed as a promising therapeutic target for OSA-associated AF, supported by preclinical studies, but further clinical research is needed.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and atrial fibrillation (AF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:32.963745+00:00"}
{"study_id": 53753, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of physical exercise on a cycle ergometer combined with CPAP in maintaining functional capacity and reducing ICU stay after coronary artery bypass graft surgery.", "results_summary": "The study found that physical exercise combined with CPAP helped maintain functional capacity and reduced ICU length of stay compared to the control group, though functional capacity decreased in both groups.", "population_specificity": "Postoperative coronary artery bypass graft surgery patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.033696+00:00"}
{"study_id": 53751, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether an intensive weight-loss program (IWLP) could reduce weight, OSA severity, and metabolic variables in obese patients with severe OSA undergoing CPAP treatment.", "results_summary": "The IWLP led to significant weight loss and reduced OSA severity at 3 months, though the AHI difference was not significant at 12 months. The intervention group also showed improvements in metabolic markers like C-reactive protein, glycated hemoglobin, and HDL cholesterol.", "population_specificity": "Obese patients (mean BMI 35 kg/m\u00b2) with severe OSA (mean AHI 69 events/h), mean age 49 years.", "effective_dosage": "Not specified (CPAP dosage not detailed in abstract).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.528952+00:00"}
{"study_id": 53755, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine if preterm infants successfully weaned from CPAP had higher oxygen saturations prior to weaning compared to those who failed weaning.", "results_summary": "Infants who successfully weaned from CPAP maintained oxygen saturations of 95-97% and 97-100% for longer durations than those who failed weaning, with statistical significance (p < 0.05).", "population_specificity": "Preterm infants \u226430 weeks' gestation receiving \u226430% FiO\u2082.", "effective_dosage": "Not specified", "study_duration": "12-month monitoring period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:33.699249+00:00"}
{"study_id": 53752, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the long-term efficacy, adherence, and satisfaction of CPAP versus MAD therapy in managing obstructive sleep apnea over a 10-year follow-up period.", "results_summary": "CPAP therapy showed a significant reduction in apnea-hypopnea index (AHI) from 49.2 \u00b1 26.1 events/h at baseline to 3.4 \u00b1 5.4 events/h at 10-year follow-up, with substantial improvement in self-reported neurobehavioral outcomes. Both CPAP and MAD demonstrated stable and effective long-term treatment effects for OSA.", "population_specificity": "103 patients with obstructive sleep apnea (52 randomized to CPAP, 17 evaluated at 10-year follow-up).", "effective_dosage": "Not specified", "study_duration": "10 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:34.268170+00:00"}
{"study_id": 53756, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the interconnectedness of obstructive sleep apnea (OSA), obesity, and disturbed glucose homeostasis, and how treating one condition (e.g., OSA with CPAP) may improve the others.", "results_summary": "The study found that CPAP treatment for OSA appears to positively influence obesity and glucose homeostasis, suggesting interconnected therapeutic benefits among these conditions. The mechanisms include both direct and indirect weight-dependent pathways.", "population_specificity": "Subjects with obesity, type 2 diabetes, and/or sleep disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:34.991405+00:00"}
{"study_id": 53757, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the short-term clinical outcomes of bubble CPAP versus other forms of CPAP in preterm infants.", "results_summary": "Bubble CPAP showed a lower risk of CPAP failure within 7 days compared to other CPAP forms, but no significant improvements in mortality or bronchopulmonary dysplasia (BPD) were observed. Nasal injury was noted as a potential adverse effect requiring monitoring.", "population_specificity": "Preterm neonates under 37 weeks' gestational age.", "effective_dosage": "Not specified", "study_duration": "Short-term (within 7 days for primary outcome)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:36.089084+00:00"}
{"study_id": 53758, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare circadian diuresis patterns in nocturnal polyuria patients with and without comorbidities, excluding those with OSA using appropriate Continuous Positive Airway Pressure.", "results_summary": "The study found no direct results regarding Continuous Positive Airway Pressure's effects, as patients using it appropriately were excluded from analysis.", "population_specificity": "Male patients with clinically significant nocturia and nocturnal polyuria, excluding those with OSA using appropriate Continuous Positive Airway Pressure.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:38.947220+00:00"}
{"study_id": 53759, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review the relationship between OSA, hypertension, and cardiovascular disease and summarize recent advances in OSA treatment, including CPAP.", "results_summary": "CPAP reduces blood pressure but has not been shown to reduce cardiovascular risk. Combining CPAP with weight loss has a synergistic effect on blood pressure and metabolic parameters, though CPAP adherence is poor.", "population_specificity": "Individuals with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:40.704910+00:00"}
{"study_id": 53760, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effectiveness and complications of high-flow nasal cannula versus continuous positive airway pressure (CPAP) for post-extubation respiratory support in preterm newborns.", "results_summary": "The study found that high-flow nasal cannula was non-inferior to CPAP in terms of therapeutic failure and resulted in significantly less nasal trauma (p < 0.00001). CPAP remained effective but was associated with higher nasal trauma rates.", "population_specificity": "Preterm newborns with a gestational age of 32 weeks or less and greater than 28 weeks.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:41.887616+00:00"}
{"study_id": 53761, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop and validate a Chinese version of the Sleep Apnea Quality of Life Index (SAQLI) for assessing quality of life in OSA patients undergoing CPAP therapy.", "results_summary": "The Chinese SAQLI demonstrated good reliability and validity, with high content validity indices (CVI) and strong internal consistency (Cronbach's \u03b1) across all domains. Repeatability tests at 7 and 30 days showed high reliability coefficients (.94 and .93, respectively).", "population_specificity": "78 patients with obstructive sleep apnea (OSA) receiving CPAP therapy at a Taiwanese teaching hospital.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:42.456143+00:00"}
{"study_id": 53762, "supplement_id": 1048, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the incidence, severity, and risk factors of nasal pressure injuries caused by NCPAP treatment in newborns.", "results_summary": "Nasal pressure injuries occurred in 34.7% of newborns receiving NCPAP, with most classified as Stage 1 or 2. Risk factors included gestational age under 32 weeks and NCPAP use exceeding 6 days.", "population_specificity": "Newborns admitted to the neonatal intensive care unit of the First Affiliated Hospital of Xiamen University, China.", "effective_dosage": "Not specified", "study_duration": "Variable, with mean injury onset at 4.72 days (range 0-30 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:42.606045+00:00"}
{"study_id": 53765, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a convenient vibratory positional therapy (PT) device was non-inferior to Continuous Positive Airway Pressure (CPAP) in treating positional obstructive sleep apnoea (POSA).", "results_summary": "CPAP was more effective than PT in reducing AHI (4.0 vs. 13.0 events/hour) and was preferred by 60% of patients, though both treatments improved symptoms compared to baseline. The study did not meet its non-inferiority endpoint for PT based on ESS changes.", "population_specificity": "Patients with positional obstructive sleep apnoea (POSA) and significant daytime sleepiness (ESS \u226510).", "effective_dosage": "Not specified", "study_duration": "8 weeks per intervention (with a 1-week washout)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:43.466518+00:00"}
{"study_id": 53766, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of nasal masks (NM), oronasal masks (ONM), and nasal masks combined with an oral shield (NMS) in preventing mouth leakage and improving sleep quality in OSA patients.", "results_summary": "The study found that NM and NMS were more effective than ONM in reducing apnea-hypopnea-index (AHI) and leakage, with no significant differences between NM and NMS. Sleep quality (NREM3) was also better with NM and NMS compared to ONM.", "population_specificity": "Patients with obstructive sleep apnea (OSA) experiencing mouth dryness (n=29).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:43.599704+00:00"}
{"study_id": 53767, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of CPAP on leptin and adiponectin levels in adults with CAD and nonsleepy OSA, adjusting for confounding factors.", "results_summary": "CPAP had no significant effect on leptin and adiponectin levels. Changes in waist circumference predicted increases in leptin, suggesting lifestyle modifications may be more impactful than CPAP in this population.", "population_specificity": "Revascularized CAD patients with OSA (AHI >15/h) and no excessive daytime sleepiness (ESS <10).", "effective_dosage": "Auto-titrating CPAP (specific dosage not mentioned).", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:44.382323+00:00"}
{"study_id": 53768, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the effects of Continuous Positive Airway Pressure (CPAP) treatment on cognitive outcomes in patients with obstructive sleep apnea (OSA), particularly focusing on its potential benefits for mild cognitive impairment (MCI) and Alzheimer's disease (AD).", "results_summary": "CPAP treatment may improve cognition in OSA patients with AD, though OSA's cognitive effects vary by age group\u2014middle-aged adults show mild impairments in attention, memory, and executive function, while older adults exhibit associations with MCI or AD development. Recent trends suggest links between OSA and AD biomarkers across all age groups.", "population_specificity": "Middle-aged and older adults with obstructive sleep apnea (OSA), including those with mild cognitive impairment (MCI) or Alzheimer's disease (AD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:48.793178+00:00"}
{"study_id": 53769, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether CPAP treatment reduces circulating malondialdehyde (MDA), a biomarker of oxidative stress, in patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP treatment significantly decreased circulating MDA in OSA patients, particularly in older, more obese, and more severe cases, as well as in patients with good compliance and longer treatment duration (\u22653 months).", "population_specificity": "Patients with obstructive sleep apnea (OSA), including subgroups of older, more obese, and more severe cases.", "effective_dosage": "Not specified", "study_duration": "Varied, with notable effects observed in treatments lasting \u22653 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:48.935563+00:00"}
{"study_id": 53770, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to assess how neonatal team leaders' visual attention varied during different respiratory interventions, including Continuous Positive Airway Pressure (CPAP), in preterm infant resuscitations.", "results_summary": "Practitioners focused less visual attention on the infant during CPAP compared to corrective ventilation steps, with gaze patterns varying by intervention type. Attending neonatologists exhibited distinct fixation sequences not seen in fellows.", "population_specificity": "Preterm infants undergoing delivery room resuscitation.", "effective_dosage": "Not specified", "study_duration": "First 5 minutes of resuscitation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:49.457243+00:00"}
{"study_id": 53775, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the accuracy of clinical event combinations during ET-CPAP in predicting successful extubation in extremely preterm neonates compared to clinical judgment alone.", "results_summary": "The study found that clinical instability during ET-CPAP was common, with 57% of neonates experiencing at least one event. Combinations of clinical events had low accuracy in predicting extubation success, suggesting SBTs may offer little added value.", "population_specificity": "Extremely preterm neonates (gestational age \u226428 weeks, birth weight <1250 g) requiring mechanical ventilation.", "effective_dosage": "Not specified", "study_duration": "5-minute ET-CPAP trial", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:51.952243+00:00"}
{"study_id": 53771, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of upper airway stimulation (UAS) as an alternative treatment for severe obstructive sleep apnoea (OSA), particularly in patients with dentofacial deformity.", "results_summary": "The study found that UAS, combined with palatopharyngoplasty, significantly improved OSA severity in a patient with severe OSA, reducing the respiratory distress index (RDI) and apnoea-hypopnoea index (AHI) to 2 events per hour and increasing minimum oxygen saturation to 83%. The patient also experienced resolution of daytime somnolence.", "population_specificity": "A 65-year-old male with a high body mass index, hypertension, diabetes, dentofacial deformity, and severe OSA (RDI 89.1, AHI 82.7, minimum oxygen saturation 75%).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:52.355318+00:00"}
{"study_id": 53773, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of suboptimal CPAP usage on objective and subjective sleepiness parameters in patients with moderate-to-severe obstructive sleep apnoea (OSA) and excessive daytime sleepiness.", "results_summary": "The study found that patients continuing therapeutic CPAP showed significantly better outcomes in sleepiness (ESS score) and blood pressure compared to those on sham CPAP, with a 90.4% probability of superiority for ESS. However, even suboptimal CPAP adherence provided substantial benefits.", "population_specificity": "Moderate-to-severe OSA patients with excessive daytime sleepiness (ESS >10) and suboptimal CPAP adherence (mean nightly usage 3-4 hours over \u226512 months).", "effective_dosage": "Not specified (subtherapeutic vs. therapeutic CPAP).", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:53.243921+00:00"}
{"study_id": 53772, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of acupuncture versus sham-acupuncture on OSA severity and blood pressure control in hypertensive patients with mild to moderate OSA.", "results_summary": "The study assessed changes in OSA severity and blood pressure after 10 acupuncture sessions, but the abstract does not specify the comparative effectiveness of CPAP versus acupuncture. CPAP was noted to reduce blood pressure but was poorly tolerated by many patients.", "population_specificity": "Hypertensive patients with mild to moderate OSA (apnea-hypopnea index 5-30 events/hr; mean age 57.0 \u00b1 5.4 years; BMI 29.6 \u00b1 3.2 kg/m\u00b2).", "effective_dosage": "Not specified for CPAP.", "study_duration": "10 acupuncture sessions (duration not specified for CPAP).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:53.601665+00:00"}
{"study_id": 53776, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess whether and how different treatments, including Continuous Positive Airway Pressure (CPAP), affect cardiac function in patients with heart failure and central sleep apnea/Cheyne-Stokes respiration (CSA/CSR).", "results_summary": "CPAP significantly improved left ventricular ejection fraction (LVEF) by 4.4% compared to an inactive control, demonstrating clinically relevant efficacy. There was no significant difference in treatment effects between CPAP and adaptive servoventilation (ASV), while nocturnal oxygen (O\u2082) had no effect on LVEF.", "population_specificity": "Patients with heart failure and central sleep apnea/Cheyne-Stokes respiration (CSA/CSR).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:53.938533+00:00"}
{"study_id": 53777, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the unclear benefits of CPAP in preventing or improving cardiovascular disease (CVD) outcomes in obstructive sleep apnea (OSA) patients and investigate the role of extracellular vesicles (EVs) in OSA-associated CVD.", "results_summary": "The abstract suggests that CPAP's benefits for CVD outcomes in OSA remain unconvincing, indicating a gap in understanding the pathophysiological mechanisms. It highlights EVs as potential biomarkers for OSA-related CVD, offering diagnostic and therapeutic insights.", "population_specificity": "Patients with obstructive sleep apnea (OSA) and associated cardiovascular diseases (CVD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:57.069448+00:00"}
{"study_id": 53779, "supplement_id": 1048, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness and tolerability of CPAP versus HFNC in treating bronchiolitis in infants and young children, focusing on respiratory outcomes and pain scores.", "results_summary": "The study found no significant differences between CPAP and HFNC in reducing respiratory rate, pCO2, or M-WCAS. However, CPAP was associated with higher pain scores (NIPS) compared to HFNC, though treatment failure was rare in both groups.", "population_specificity": "Infants and young children with bronchiolitis (median age 2.8 months in CPAP group, 2.1 months in HFNC group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:58.456965+00:00"}
{"study_id": 53778, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether obstructive sleep apnea (OSA) and its treatment with continuous positive airway pressure (CPAP) affected the clinical outcomes of patients with acute coronary syndrome (ACS).", "results_summary": "The study found no significant difference in cardiovascular event prevalence between CPAP-treated and usual care groups, nor between OSA and non-OSA patients. CPAP adherence averaged 2.78 hours/night but did not correlate with improved outcomes.", "population_specificity": "Non-sleepy adults (\u226518 years) admitted for ACS, with or without OSA.", "effective_dosage": "Not specified (adherence averaged 2.78 hours/night).", "study_duration": "Median follow-up of 3.35 years (IQR 1.50\u20135.31).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:31:59.261232+00:00"}
{"study_id": 53781, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the management of chlorine gas exposure, including the potential use of Continuous Positive Airway Pressure (CPAP) for severe respiratory distress.", "results_summary": "The study suggests that CPAP or mechanical ventilation with high positive-end-expiratory-pressure may be necessary in cases of severe chlorine gas exposure leading to ARDS, but does not provide specific efficacy data for CPAP alone.", "population_specificity": "Individuals exposed to chlorine gas, including household, industrial, or chemical warfare scenarios.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:00.176795+00:00"}
{"study_id": 53784, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to explore changes in DNA methylation levels among adults with obstructive sleep apnea (OSA) and diabetes after 12 weeks of CPAP treatment.", "results_summary": "The study observed small changes in DNA methylation levels after CPAP treatment, but the causal mechanism remains unclear, and long-term effects are unknown.", "population_specificity": "Adults with OSA and diabetes (70% female, 80% white, mean age 61.7\u00b17.9 years).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:01.465145+00:00"}
{"study_id": 53782, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the Linshom temperature profile amplitude could serve as an accurate surrogate for tidal volume (V) measurements in patients using a continuous positive airway pressure mask.", "results_summary": "The study found that fluctuations in the Linshom temperature profile amplitude closely tracked changes in tidal volume (V), supporting its reliability as a surrogate metric. Data from 30 volunteers were analyzed, with 10 excluded due to protocol violations or technical issues unrelated to the device.", "population_specificity": "Forty volunteers breathing room air spontaneously through a tight-fitting continuous positive airway pressure mask.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:01.682448+00:00"}
{"study_id": 53783, "supplement_id": 1048, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the clinical effectiveness of continuous positive airway pressure (CPAP) in improving quality of life for patients with mild obstructive sleep apnoea.", "results_summary": "CPAP significantly improved vitality scores compared to standard care alone, with a mean treatment effect of 10.0 points (p<0.0001). The study also reported no serious adverse events related to the intervention.", "population_specificity": "Adults aged 18-80 with mild obstructive sleep apnoea (AHI 5-15 events per hour) diagnosed using AASM 2012 criteria.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:02.494062+00:00"}
{"study_id": 53780, "supplement_id": 1048, "safety_score": "85", "efficacy_score": 90, "quality_score": 75, "study_goal": "The researchers aimed to assess the feasibility, efficacy, and safety of minimally invasive surfactant therapy (MIST) using nasal continuous positive airway pressure (nCPAP) for very low birth weight infants with respiratory distress syndrome (RDS).", "results_summary": "Infants receiving MIST under nCPAP had significantly lower rates of death or bronchopulmonary dysplasia, shorter durations of mechanical ventilation, and reduced need for patent ductus arteriosus treatments compared to those receiving traditional intubation and surfactant therapy. The study concluded that MIST is feasible, safe, and may improve outcomes for preterm infants with RDS.", "population_specificity": "Very low birth weight infants born before 32 gestational weeks with spontaneous breathing and respiratory distress requiring surfactant therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:03.277178+00:00"}
{"study_id": 53785, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 65, "quality_score": 80, "study_goal": "To determine the effects of positive pressure modification or humidification on increasing CPAP machine usage in adults with OSA.", "results_summary": "Auto-CPAP probably increases machine usage by about 13 minutes per night, but effects on daytime sleepiness scores are not clinically meaningful. AHI values are slightly lower with fixed CPAP, and quality of life effects were limited.", "population_specificity": "Adults with moderate to severe obstructive sleep apnoea (OSA), predominantly male (75%), recently diagnosed, and CPAP-na\u00efve.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:05.157622+00:00"}
{"study_id": 53787, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review treatment options, including Continuous Positive Airway Pressure (CPAP), for pediatric obstructive sleep apnea (OSA).", "results_summary": "The abstract indicates CPAP is a commonly used medical treatment for pediatric OSA, but specific efficacy results are not detailed. Management of pediatric OSA is described as multidisciplinary, involving both surgical and medical options.", "population_specificity": "Pediatric patients, particularly obese children with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:07.006061+00:00"}
{"study_id": 53786, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of home sleep apnea testing followed by autotitrating continuous positive airway pressure therapy in reducing barriers to OSA diagnosis and treatment.", "results_summary": "The study found that home sleep apnea testing and autotitrating CPAP therapy significantly reduced barriers to OSA diagnosis and treatment, facilitating routine management by primary care providers. It also highlighted the potential to alleviate symptoms and decrease cardiovascular risk in symptomatic patients.", "population_specificity": "Symptomatic patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:08.116725+00:00"}
{"study_id": 53790, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate factors affecting CPAP adherence, particularly mask selection, and compare the suitability of nasal versus oronasal masks.", "results_summary": "CPAP fails in one-third of patients due to poor adherence, often linked to mask choice. Nasal masks are generally more suitable than oronasal masks, except in cases of nasal stuffiness or mouth leaks. Mask brand does not impact adherence once a suitable mask is selected.", "population_specificity": "Patients with sleep apnea using CPAP therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:09.864647+00:00"}
{"study_id": 53789, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the feasibility, morbidity, and efficacy of transoral robotic surgery (TORS) tongue-base resection combined with tongue-base suspension for obstructive sleep apnea (OSA) with tongue-base collapse, specifically in patients who failed continuous positive airway pressure (CPAP).", "results_summary": "The study found that TORS-TBR combined with TBS is feasible, safe, and efficient for OSA with tongue-base collapse in patients who failed CPAP, but the abstract does not provide specific efficacy or safety data for CPAP itself.", "population_specificity": "Patients with moderate-to-severe OSA (AHI > 15) or positional OSA, tongue-base collapse, and glossoptosis identified by DISE, who failed CPAP.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:10.958239+00:00"}
{"study_id": 53791, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the mechanistic association between sleep loss, the GH/IGF-1 axis, and cognitive capacities, and to evaluate non-pharmacological countermeasures like Continuous Positive Airway Pressure (CPAP) for mitigating sleep loss effects.", "results_summary": "The study suggests that CPAP therapy, among other strategies, may help limit the deleterious consequences of sleep loss/disorders, particularly in patients with obstructive sleep apnea (OSA), by addressing inflammatory/endocrine pathways and cognitive impairments.", "population_specificity": "Healthy individuals and patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:11.281655+00:00"}
{"study_id": 53792, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the clinical effectiveness and safety of nasal continuous positive airway pressure (nCPAP) with bilevel positive airway pressure (BiPAP) as initial respiratory support in preterm infants with respiratory distress.", "results_summary": "The study found no statistically significant difference in treatment failure between nCPAP and BiPAP, concluding that nCPAP is not inferior to BiPAP for initial management of respiratory distress in premature infants.", "population_specificity": "Preterm infants with gestational ages between 30 and 35 weeks.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:11.348755+00:00"}
{"study_id": 53793, "supplement_id": 1048, "safety_score": "70", "efficacy_score": 90, "quality_score": 85, "study_goal": "To compare the efficacy of tongue-retaining device (TRD) versus continuous positive airway pressure (CPAP) for treating obstructive sleep apnea (OSA).", "results_summary": "CPAP was superior to TRD in reducing apnea-hypopnea index (AHI), but both treatments similarly improved quality of life and daytime sleepiness. Common adverse effects for CPAP included nasal blockage, mask compression, and difficult portability.", "population_specificity": "36 patients (27 analyzed) with OSA, mean age 52.7 \u00b1 10.6 years, AHI \u2265 5 events/h.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:13.777122+00:00"}
{"study_id": 53794, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to directly compare objective adherence between mandibular advancement device (MAD) and continuous positive airway pressure (CPAP) therapy in patients with moderate obstructive sleep apnea (OSA).", "results_summary": "Objective adherence with CPAP was comparable to MAD over 12 months, with no significant differences between the two therapies. Self-reported adherence was higher with MAD than CPAP, but objective CPAP adherence was higher than self-reported CPAP adherence at later follow-ups.", "population_specificity": "59 patients with moderate OSA (apnea-hypopnea index 15-30 events/h).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:15.890366+00:00"}
{"study_id": 53795, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of Continuous Positive Airway Pressure (CPAP) therapy on short-term and long-term outcomes in heart failure patients with sleep-disordered breathing.", "results_summary": "CPAP therapy was found to improve both short-term and long-term outcomes in heart failure patients with sleep-disordered breathing, including obstructive sleep apnea and central sleep apnea. The abstract also notes that adaptive servoventilation (ASV) is not recommended for low-EF heart failure patients with predominant central sleep apnea, while phrenic nerve stimulation shows promise as an emerging treatment.", "population_specificity": "Patients with heart failure and sleep-disordered breathing (including obstructive sleep apnea, central sleep apnea, and Cheyne-Stokes respiration).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:17.581785+00:00"}
{"study_id": 53796, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of continuous positive airway pressure (CPAP) versus sham CPAP on blood pressure in individuals with obstructive sleep apnea.", "results_summary": "CPAP therapy resulted in a modest reduction in morning systolic blood pressure (approximately 2.4 mmHg at 2 months) compared to sham treatment, but the effect diminished and became non-significant by 6 months. No significant impact on evening blood pressure was observed.", "population_specificity": "1,101 participants with obstructive sleep apnea (apnea-hypopnea index \u2265 10).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:18.766296+00:00"}
{"study_id": 53788, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify baseline phenotypic characteristics of responders to Mandibular Advancement Device (MAD) therapy in obstructive sleep apnea (OSA) patients, comparing it to Continuous Positive Airway Pressure (CPAP).", "results_summary": "The meta-analysis found that responders to MAD therapy had specific clinical characteristics, including lower age, female sex, lower BMI, smaller neck circumference, and specific craniofacial features. These findings help clinicians predict MAD efficacy but do not directly assess CPAP efficacy.", "population_specificity": "OSA patients considered for MAD therapy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:18.926670+00:00"}
{"study_id": 53798, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 22, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the performance of clinical criteria for diagnosing and initiating CPAP treatment in suspected OSA patients compared to decisions based on sleep studies and physician experience.", "results_summary": "The study found that CPAP indication without a sleep study had low sensitivity (~22%) but high specificity (>95%) in patients with high pretest probability for OSA (snoring, frequent apneas, BMI > 25 kg/m\u00b2).", "population_specificity": "653 patients (40% women, median age 54, BMI 28 kg/m\u00b2) with suspected obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:19.576385+00:00"}
{"study_id": 53799, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to clarify the effect of CPAP on erectile function in OSA patients with concurrent ED and compare its efficacy to PDE5i and combination therapy.", "results_summary": "CPAP significantly improved IIEF score, TEE, and NPR but not NPTC. It was inferior to PDE5i in some domains but more effective in improving TEE. Combination therapy (CPAP + PDE5i) outperformed CPAP alone in improving IIEF score, SAIR, and TEE.", "population_specificity": "OSA patients with concurrent ED", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:19.601355+00:00"}
{"study_id": 53797, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of viral coinfections on the clinical course and treatment response of bronchiolitis in infants treated with high-flow nasal cannula (HFNC), including potential escalation to Helmet-Continuous Positive Airway Pressure.", "results_summary": "The study found that viral coinfection was associated with worsened severity scores, longer HFNC treatment duration, and higher likelihood of atelectasis, but did not significantly influence HFNC failure rates or the need for escalation to Continuous Positive Airway Pressure. No differences were observed based on the number or type of viruses detected.", "population_specificity": "120 children under 12 months admitted to the Emergency Department with bronchiolitis between 2016 and 2018.", "effective_dosage": "Not specified", "study_duration": "Treatment duration varied, with outcomes assessed within 48 hours of HFNC initiation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:20.984359+00:00"}
{"study_id": 53800, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers were evaluating the effectiveness and patient preference of hypoglossal nerve stimulation compared to continuous positive airway pressure (CPAP) for treating obstructive sleep apnea (OSA).", "results_summary": "Hypoglossal nerve stimulation showed an over 80% success rate in treating OSA, with patients reporting improved symptoms, high adherence rates, and a preference for this therapy over CPAP.", "population_specificity": "Patients with obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:21.135900+00:00"}
{"study_id": 53802, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of auto-PAP (aPAP) with and without the SensAwake\u2122 (SA) algorithm in improving adherence and sleep-related symptoms in patients with comorbid OSA and PTSD.", "results_summary": "The study found that aPAP with SA significantly improved adherence (hours of use and percentage of nights used \u22654h) compared to standard aPAP, though some secondary adherence measures showed only trends. Both groups showed significant improvements in sleep-related symptoms, but no differences in symptom improvement magnitude were observed between groups.", "population_specificity": "Patients with comorbid obstructive sleep apnea (OSA) and post-traumatic stress disorder (PTSD) who were PAP na\u00efve.", "effective_dosage": "Not specified", "study_duration": "8 weeks (4 weeks per treatment arm in a crossover design)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:25.956999+00:00"}
{"study_id": 53806, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "To evaluate the effect of CPAP on quality of life (QoL) in obstructive sleep apnoea (OSA) patients compared to sham CPAP, placebo pills, and conservative treatment.", "results_summary": "Meta-analysis showed no significant differences in overall and psychological QoL between CPAP-treated patients and controls, but physical QoL improved. CPAP significantly affected overall QoL in studies with sham CPAP controls, parallel design, low risk of bias, and mild OSA patients.", "population_specificity": "Obstructive sleep apnoea (OSA) patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:25.965075+00:00"}
{"study_id": 53808, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to describe the clinical characteristics of ASV-treated patients in real-life conditions and assess the safety and rational use of ASV.", "results_summary": "The study found that ASV-treatment in real-life conditions is often associated with high cardiac comorbidities and high compliance, suggesting potential benefits but also highlighting the need for further research on optimizing device settings and patient management.", "population_specificity": "Patients who underwent ASV-treatment for at least 1 year (87.57% male).", "effective_dosage": "Not specified", "study_duration": "At least 1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:27.239957+00:00"}
{"study_id": 53807, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of different titration methods (DISE-assisted, PSG-guided, and conventional subjective) for optimizing mandibular protrusion in MAD therapy, analogous to CPAP titration.", "results_summary": "The study proposes to compare three titration procedures for mandibular advancement devices, focusing on identifying the most optimal protrusive position and therapeutic efficacy, but results are not yet available as it is a randomized crossover trial in progress.", "population_specificity": "Patients diagnosed with obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:27.309233+00:00"}
{"study_id": 53811, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify factors predicting non-completion of a specialist obesity management program, including the role of CPAP therapy for obstructive sleep apnea.", "results_summary": "The study found that patients using CPAP therapy were less likely to drop out of the program (11.7% non-completers vs. 28.4% completers), suggesting CPAP may improve engagement in obesity management. However, CPAP was not the primary focus of the study.", "population_specificity": "Adults with clinically severe obesity (BMI \u226535 kg/m\u00b2) enrolled in a Metabolic Rehabilitation Programme.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:28.516976+00:00"}
{"study_id": 53810, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the long-term effects of CPAP on breathing patterns, ventilatory drive, and chemoreceptor sensitivity in patients with obstructive sleep apnea (OSA).", "results_summary": "CPAP treatment reduced ventilatory drive and thoracic/inspiratory impedances in OSA patients, starting from the titration night, particularly in those with good compliance. It improved respiratory efficiency and normalized hypoxemic stimulus.", "population_specificity": "62 OSA patients (mean age 51 \u00b1 11 years) from an academic sleep outpatient clinic.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:28.975547+00:00"}
{"study_id": 53812, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the clinical improvement and cost-effectiveness of an out-of-hospital Virtual Sleep Unit (VSU) versus hospital routine (HR) for managing suspected OSA, including patients with and without CPAP therapy.", "results_summary": "CPAP compliance was similar in both groups, but clinical improvement varied by questionnaire\u2014QSQ social interactions improved more in HR, while EQ-VAS improved more in VSU. VSU was more cost-effective than HR, particularly in terms of QALYs.", "population_specificity": "Patients with suspected obstructive sleep apnea (OSA).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:29.683348+00:00"}
{"study_id": 53813, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of continuous positive airway pressure (CPAP) therapy on reducing the excess risk of motor vehicle accidents in patients with obstructive sleep apnea (OSA).", "results_summary": "The study found that CPAP therapy can eliminate the increased risk of motor vehicle accidents in OSA patients, who are otherwise 2-3 times more likely to have such accidents compared to the general population. Several jurisdictions have implemented regulations restricting driving for untreated OSA patients with sleepiness until effective treatment is established.", "population_specificity": "Patients with moderate or severe obstructive sleep apnea (OSA) associated with sleepiness.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:31.038744+00:00"}
{"study_id": 53814, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of Continuous Positive Airway Pressure (CPAP) in reducing driving accident risk and the challenges of assessing sleepiness and treatment adherence in obstructive sleep apnea patients.", "results_summary": "CPAP effectively reduces the risk of driving accidents in obstructive sleep apnea patients, but compliance with treatment is often suboptimal. There is uncertainty about the best methods to assess sleepiness and adherence on a large scale.", "population_specificity": "Patients with obstructive sleep apnea, particularly those at risk of excessive daytime sleepiness and driving accidents.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:35.110459+00:00"}
{"study_id": 53816, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine whether CPAP treatment for obstructive sleep apnea (OSA) could reduce uric acid (UA) levels.", "results_summary": "The meta-analysis found no significant change in UA levels before and after CPAP treatment in OSA patients (SMD = -0.20, 95% CI: -0.78 to 0.37). The study concluded that CPAP treatment has no effect on UA levels in this population.", "population_specificity": "270 patients with obstructive sleep apnea (OSA) from 5 studies (2 RCTs and 3 observational studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:35.754103+00:00"}
{"study_id": 53817, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify predictors and outcomes of early intubation in preterm infants with respiratory distress, comparing nasal high-flow with continuous positive airway pressure (CPAP) as primary respiratory support.", "results_summary": "The study found that lower gestational age and higher pre-randomization fraction of inspired oxygen (FiO\u2082) were predictors of early intubation in preterm infants receiving noninvasive respiratory support. CPAP was part of the comparison but specific efficacy relative to nasal high-flow was not detailed in the abstract.", "population_specificity": "Preterm infants born at 28-36 weeks of gestation with respiratory distress.", "effective_dosage": "Not specified", "study_duration": "Intubation was assessed within 72 hours of randomization.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:36.057596+00:00"}
{"study_id": 53815, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if Continuous Positive Airway Pressure (CPAP) could more rapidly reduce carboxyhemoglobin levels and alleviate symptoms in patients with carbon monoxide intoxication compared to high-flow oxygen therapy.", "results_summary": "CPAP significantly reduced carboxyhemoglobin levels (13% median difference vs. 6% in the control group) and symptoms (5-unit decrease vs. 2-unit decrease in the control group) within 30 minutes, demonstrating faster improvement than high-flow oxygen therapy.", "population_specificity": "Patients presenting at emergency departments with carbon monoxide intoxication.", "effective_dosage": "FiO2 1.0 oxygen at 12 cmH2O pressure via non-invasive mechanical ventilation.", "study_duration": "At least 30 minutes.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:36.090663+00:00"}
{"study_id": 53818, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the long-term efficacy and tolerability of mandibular repositioning device (MRD) therapy as an alternative to continuous positive airway pressure (CPAP) in patients with obstructive sleep apnoea syndrome (OSAS).", "results_summary": "At two years, 67% of patients achieved a \u226550% reduction in the apnoea-hypopnoea index (AHI), with 30%, 56%, and 72% achieving AHI <5/h, <10/h, and <15/h, respectively. Adverse events were generally mild and mostly occurred in the first year.", "population_specificity": "Patients with mild to severe OSAS who refused or were noncompliant with CPAP.", "effective_dosage": "Not specified (individually titrated mandibular advancement).", "study_duration": "Two years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:38.320837+00:00"}
{"study_id": 53820, "supplement_id": 1048, "safety_score": "75", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and efficacy of bCPAP for children with respiratory distress in LMICs, assess implemented bCPAP devices, and determine the settings where bCPAP has been used.", "results_summary": "bCPAP improved survival and clinical progression in neonates and reduced mortality in children aged 29 days to 13 months compared to oxygen therapy. Respiratory rate reductions were significant across all ages, but limited data on serious adverse events were available.", "population_specificity": "Neonates and children up to 13 months in low- and middle-income countries (LMICs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:38.437262+00:00"}
{"study_id": 53819, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and impact of Continuous Positive Airway Pressure (CPAP) in treating central sleep apnoea (CSA) in heart failure patients, particularly comparing its effects to adaptive servoventilation (ASV).", "results_summary": "CPAP reduced breathing disturbances by 50% in heart failure patients with CSA, but adaptive servoventilation (ASV) was more effective in normalizing breathing disturbances. However, the impact of ASV on hard outcomes like mortality was contradictory, with some studies showing survival improvement and others indicating excess mortality in specific heart failure subgroups.", "population_specificity": "Heart failure patients, including those with preserved and reduced ejection fraction, suffering from central sleep apnoea (CSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:38.630939+00:00"}
{"study_id": 53821, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if stable OHS patients successfully treated with NIV could be safely and effectively switched to CPAP therapy.", "results_summary": "The study found that 71% of patients maintained stable daytime PaCO2 levels after switching from NIV to CPAP, suggesting feasibility and potential cost savings. The auto-adjusted CPAP combined with PSG and capnometry was validated as an effective titration method.", "population_specificity": "Stable OHS patients with a history of severe obstructive sleep apnea syndrome, 52% of whom also had mild-to-moderate COPD (GOLD I/II).", "effective_dosage": "Fixed CPAP (specific pressure not stated)", "study_duration": "4-6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:40.401803+00:00"}
{"study_id": 53822, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the clinical and cost-effectiveness of CPAP therapy versus MAD therapy in patients with moderate obstructive sleep apnea (OSA).", "results_summary": "CPAP showed significantly greater AHI reduction compared to MAD after 12 months and was more cost-effective, though MAD performed better in terms of cost per QALY gained. CPAP was concluded as the first-choice treatment for moderate OSA, with MAD as a potential alternative.", "population_specificity": "Patients with moderate OSA (AHI 15-30 events/h).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:43.255935+00:00"}
{"study_id": 53827, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of Continuous Positive Airway Pressure (CPAP) as a symptomatic treatment for stridor in Multiple System Atrophy (MSA) and assess its impact on survival and quality of life.", "results_summary": "The study found that CPAP is suggested as a symptomatic treatment for stridor in MSA, but its impact on survival and quality of life remains uncertain. No definitive conclusions were drawn about its efficacy in improving survival.", "population_specificity": "Patients with Multiple System Atrophy (MSA) presenting with laryngeal stridor.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:44.390623+00:00"}
{"study_id": 53825, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify predictors of long-term adherence to CPAP therapy in patients with moderate-to-severe obstructive sleep apnea (OSA) and established cardiovascular disease.", "results_summary": "Early CPAP adherence measures, improvement in daytime sleepiness at 1 month, fixed CPAP pressure, and very loud snoring were significant predictors of long-term adherence. Adherence varied between countries, but early adherence retained independent predictive value in the multivariate model.", "population_specificity": "Adults aged 45-75 with moderate-to-severe OSA (\u226512 episodes/h of \u22654% oxygen desaturation) and established cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:44.898377+00:00"}
{"study_id": 53823, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the effects of Continuous Positive Airway Pressure (CPAP) on ocular signs and symptoms in patients with Floppy Eyelid Syndrome (FES) and obstructive sleep apnea.", "results_summary": "The study found that long-term CPAP therapy may improve ocular signs and symptoms in patients with FES and obstructive sleep apnea. Refractory cases may require corrective surgery for significant improvement.", "population_specificity": "Patients with Floppy Eyelid Syndrome (FES) and obstructive sleep apnea.", "effective_dosage": "Not specified", "study_duration": "Long-term (specific duration not mentioned)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:48.022081+00:00"}
{"study_id": 53829, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of telemonitoring, usual care, and phone-call care on compliance and efficacy of Continuous Positive Airway Pressure (CPAP) in patients with obstructive sleep apnoea.", "results_summary": "Telemonitoring did not significantly improve CPAP compliance or efficacy compared to usual care or phone-call care. All groups showed similar residual Apnoea-Hypopnoea Index values, with no statistically significant differences.", "population_specificity": "51 patients (82.4% male, aged 25-78) diagnosed with moderate to severe obstructive sleep apnoea.", "effective_dosage": "Not specified (AutoSet Spirit S8\u00ae device used).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:48.455261+00:00"}
{"study_id": 53830, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of high flow nasal cannula (HFNC) and nasal continuous positive airway pressure (nCPAP) as primary respiratory support in preterm infants \u226432 weeks of gestational age within the first hour of life.", "results_summary": "The study found no significant differences between HFNC and nCPAP in terms of primary treatment failure, duration of noninvasive respiratory support, oxygen treatment, or complications of prematurity. Both methods showed similar efficacy in respiratory support for preterm infants.", "population_specificity": "Preterm infants \u226432 weeks of gestational age with spontaneous respiration.", "effective_dosage": "Not specified", "study_duration": "First hour of life and subsequent ICU admission (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:48.496582+00:00"}
{"study_id": 53828, "supplement_id": 1048, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy of high-flow nasal cannula (HFNC) oxygen therapy versus standard oxygen therapy or nasal continuous positive airway pressure (nCPAP) in reducing treatment failure among children with acute lower respiratory infection (ALRI), hypoxemia, and respiratory distress.", "results_summary": "HFNC reduced treatment failure compared to standard oxygen therapy in children with mild hypoxemia, but nCPAP was more effective than HFNC in infants aged 1-6 months with ALRI, moderate-to-severe respiratory distress, and severe hypoxemia. No differences were found in intubation and mortality rates between HFNC and standard oxygen therapy or nCPAP.", "population_specificity": "Children under 5 years of age with ALRI, respiratory distress, and hypoxemia (mild to severe, depending on subgroup).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:49.622813+00:00"}
{"study_id": 53831, "supplement_id": 1048, "safety_score": "65", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether bCPAP reduces hospital mortality among high-risk Malawian children with severe pneumonia in non-intensive care settings compared to oxygen therapy.", "results_summary": "bCPAP did not reduce hospital mortality compared to oxygen (17% vs. 11% mortality) and was associated with higher adverse events, including probable aspiration episodes and pneumothorax. The trial was stopped early for futility.", "population_specificity": "Children aged 1-59 months in Malawi with severe pneumonia and HIV infection/exposure, severe malnutrition, or hypoxemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:32:52.372749+00:00"}
{"study_id": 64275, "supplement_id": 1059, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the physiological effects and clinical efficacy of cryotherapy for acute musculoskeletal injury and delayed-onset muscle soreness (DOMS).", "results_summary": "The study found that cryotherapy reduces pain, blood flow, edema, inflammation, muscle spasm, and metabolic demand, but evidence from RCTs supporting its use is limited.", "population_specificity": "Patients with acute musculoskeletal injury and delayed-onset muscle soreness (DOMS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:00.001120+00:00"}
{"study_id": 64278, "supplement_id": 1059, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the outcomes of cryotherapy compared to other treatments and explore its potential uses in surgery, particularly for prostate and renal cancers.", "results_summary": "The study found that cryotherapy is an effective minimally invasive treatment for localized prostate and renal cancers, offering benefits such as reduced perioperative complications and minimal morbidities, especially for stage T1a renal masses.", "population_specificity": "Patients with localized prostate cancer and stage T1a renal cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:00.274444+00:00"}
{"study_id": 64276, "supplement_id": 1059, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review existing and emerging treatments for metastatic melanoma, including cryotherapy, and explore combination therapy strategies.", "results_summary": "The abstract mentions cryotherapy as one of the existing options for managing cutaneous and subcutaneous metastases in melanoma but does not provide specific findings about its effects.", "population_specificity": "Patients with Stage IV melanoma, particularly those with cutaneous and subcutaneous metastases.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:02.359160+00:00"}
{"study_id": 64273, "supplement_id": 1059, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and role of cryotherapy as a lesion-directed therapy for actinic keratosis (AK) compared to other topical treatments.", "results_summary": "Cryotherapy is recommended for treating single AK lesions, demonstrating effectiveness as a lesion-directed therapy, while topical medical therapies are preferred for multiple lesions. Combined or sequential therapies are proposed to enhance efficacy and tolerability.", "population_specificity": "Patients with actinic keratosis (AK), particularly those with single lesions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:03.107285+00:00"}
